THE FOUNDATION FOR AIDS RESEARCH: Form 990, tax year 2016
View the entire original 990 at ProPublica ↗
- Organization
- THE FOUNDATION FOR AIDS RESEARCH (EIN 13-3163817)
- Tax period
- 2016-10-01 to 2017-09-30
- Filed
- 2018-07-16
- IRS object ID
- 201841979349300869
- Schema version
- 2016v3.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2018-07-16T15:40:02-05:00 | ReturnTs |
| Tax Period End | 2017-09-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | GRANT THORNTON LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 757 THIRD AVENUE 3RD FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100172013 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2016-10-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 133163817 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE FOUNDATION FOR AIDS RESEARCH | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % BRADLEY JENSEN | InCareOfNm |
| Business Name Control | FOUN | BusinessNameControlTxt |
| Phone | 2128061600 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 120 wall street 13TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100053908 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | BRADLEY JENSEN | PersonNm |
| Person Title | ASSISTANT TREAS./CFO | PersonTitleTxt |
| Phone | 2128061703 | PhoneNum |
| Signature | 2018-07-16 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Scott Thompsett | PreparerPersonNm |
| PTIN | P00741490 | PTIN |
| Phone | 2125990100 | PhoneNum |
| Preparation | 2018-07-16 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2016 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Aids Research Foundation or amfAR | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | KEVIN FROST | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 120 WALL STREET 13TH FLOOR | AddressLine1Txt |
| City | new york | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10005 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $65,592,839 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.AMFAR.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1983 | FormationYr |
| Legal Domicile State | NY | LegalDomicileStateCd |
| Activity Or Mission | AMFAR IS DEDICATED TO ENDING THE GLOBAL AIDS EPIDEMIC THROUGH INNOVATIVE RESEARCH. | ActivityOrMissionDesc |
| Voting Members Governing Body | 15 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 15 | VotingMembersIndependentCnt |
| Total Employee | 88 | TotalEmployeeCnt |
| Total Volunteers | 0 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| PY Contributions Grants | $58,810,206 | PYContributionsGrantsAmt |
| CY Contributions Grants | $50,842,378 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $1,108,834 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,434,528 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$11,056,842 | PYOtherRevenueAmt |
| CY Other Revenue | -$11,850,334 | CYOtherRevenueAmt |
| PY Total Revenue | $48,862,198 | PYTotalRevenueAmt |
| CY Total Revenue | $40,426,572 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $10,349,259 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $12,204,275 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $10,487,770 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $11,102,574 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $854,723 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $746,863 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $5,698,108 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $19,985,556 | PYOtherExpensesAmt |
| CY Other Expenses | $19,193,671 | CYOtherExpensesAmt |
| PY Total Expenses | $41,677,308 | PYTotalExpensesAmt |
| CY Total Expenses | $43,247,383 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $7,184,890 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$2,820,811 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $80,773,661 | TotalAssetsBOYAmt |
| Total Assets EOY | $80,221,720 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $19,134,481 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $20,491,474 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $61,639,180 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $59,730,246 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE FOUNDATION FOR AIDS RESEARCH IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION INCORPORATED IN NEW YORK IN 1989. AMFAR WAS FORMED THROUGH THE UNIFICATION IN 1985 OF TWO NOT-FOR-PROFIT ORGANIZATIONS, THE AIDS MEDICAL FOUNDATION ("AMF"), INCORPORATED IN NEW YORK IN APRIL 1983, AND THE NATIONAL AIDS RESEARCH FOUNDATION, INCORPORATED IN CALIFORNIA IN AUGUST 1985. FIRST BASED IN CALIFORNIA, AMFAR TRANSFERRED ITS LEGAL DOMICILE TO NEW YORK IN 1989, USING THE INITIAL INCORPORATION DOCUMENTS OF AMF, MAKING IT AMF'S LEGAL SUCCESSOR. AMFAR HAS OFFICES IN NEW YORK, NY, WASHINGTON, D.C., AND BANGKOK, THAILAND. ON MARCH 7, 2005, THE BOARD OF TRUSTEES OF THE AMERICAN FOUNDATION FOR AIDS RESEARCH APPROVED A CHANGE IN LEGAL NAME TO "THE FOUNDATION FOR AIDS RESEARCH. "ON OCTOBER 18, 2005, THE NEW YORK STATE DEPARTMENT OF STATE APPROVED THIS CHANGE. IN ADDITION, THE FOUNDATION HAS SECURED APPROVAL FOR DOING BUSINESS AS (DBA) THE FOLLOWING: - AMERICAN FOUNDATION FOR AIDS RESEARCH - AMFAR - AIDS RESEARC | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $22,602,651 | ExpenseAmt |
| Grant | $9,179,568 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | RESEARCH: AMFAR SUPPORTS RESEARCH PROJECTS THAT EXPLORE NOVEL APPROACHES TO SCIENTIFICALLY SOUND BUT UNTESTED HYPOTHESES IN ALL AREAS OF RESEARCH ON HIV/AIDS, FUNDING GOAL-ORIENTED STUDIES THAT OFTEN LACK THE PRELIMINARY DATA REQUIRED FOR SUPPORT FROM TRADITIONAL GRANT MAKERS. THE FOUNDATION PLAYS A VITAL ROLE IN HIV/AIDS RESEARCH, IDENTIFYING CRITICAL GAPS IN KNOWLEDGE AND PROVIDING ESSENTIAL SEED MONEY THAT ENABLES GRANTEES AND FELLOWS TO TEST THE MERITS OF NEW CONCEPTS OR TECHNOLOGIES THAT SUBSEQUENTLY CAN BE VALIDATED THROUGH LARGE-SCALE STUDIES, SUCH AS THOSE FUNDED BY THE U.S. NATIONAL INSTITUTES OF HEALTH. FOR FURTHER DETAILS, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $4,581,510 | ExpenseAmt |
| Grant | $2,065,471 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | TREAT ASIA: AMFAR'S TREAT ASIA (THERAPEUTICS RESEARCH, EDUCATION, AND AIDS TRAINING IN ASIA) PROGRAM IS A NETWORK OF HOSPITALS, CLINICS, AND RESEARCH INSTITUTIONS WORKING WITH CIVIL SOCIETY TO ENSURE THE SAFE AND EFFECTIVE DELIVERY OF HIV TREATMENTS TO ADULTS AND CHILDREN ACROSS THE ASIA-PACIFIC THROUGH RESEARCH, EDUCATION, AND ADVOCACY OF EVIDENCE-BASED HIV-RELATED POLICIES. THE TREAT ASIA NETWORK ENCOMPASSES 21 ADULT AND 20 PEDIATRIC SITES THROUGHOUT THE REGION, WHICH COLLABORATE ON A VARIETY OF PROJECTS. FOR FURTHER DETAILS, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $4,217,812 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | PUBLIC INFORMATION: AMFAR SEEKS TO TRANSLATE AND DISSEMINATE INFORMATION ON IMPORTANT AIDS-RELATED RESEARCH, TREATMENT, PREVENTION, AND POLICY ISSUES FOR DIVERSE AUDIENCES AND TO INCREASE BROAD AWARENESS AND KNOWLEDGE OF THE PANDEMIC. AMFAR ALSO PUBLISHES A WIDE RANGE OF EDUCATIONAL MATERIALS, MAINTAINS AN INFORMATIVE WEBSITE, AND ENGAGES RESPECTED PUBLIC FIGURES, HIV/AIDS SCIENTISTS, AND POLICYMAKERS IN COMMUNICATING THE NEED FOR CONTINUED RESEARCH TO DEVELOP NEW METHODS OF PREVENTION, TREATMENT, AND, ULTIMATELY, A CURE FOR HIV. FOR FURTHER DETAILS, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)
| ExpenseExpenseAmt | GrantGrantAmt | RevenueRevenueAmt | DescDesc |
|---|---|---|---|
| $2,202,676 | $217,869 | $0 | public policy |
| $1,260,903 | $741,367 | $0 | GMT Initiative |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $3,463,579 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $959,236 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $0 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $34,865,552 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | Yes (true) | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | false | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 119 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 88 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | TH | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 15 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 15 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | BRADLEY JENSEN | PersonNm |
| Phone | 2128061703 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 120 WALL STREET 13TH FLOOR | AddressLine1Txt |
| City | new york | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100053908 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (39 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| Mathilde Krim PhD | |||||||||
| Founding Chairman | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Kenneth Cole | |||||||||
| Chairman of the Board | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Patricia J Matson | |||||||||
| Vice Chairman | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| John C Simons | |||||||||
| Vice Chairman AND TREASURER | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Mervyn F Silverman MDMPH | |||||||||
| Secretary | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Arlen H Andelson | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Harry Belafonte | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| David Bohnett | |||||||||
| Trustee (NON-VOT.) (Thru 8/17) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Zev Braun | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Jonathan S Canno | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Donald Capoccia | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| R Martin Chavez PhD | |||||||||
| Trustee (Thru 1/2017) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Jane B Eisner | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| T Ryan Greenawalt | |||||||||
| Trustee (Thru 8/2017) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Regan Hofmann | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Michael J Klingensmith | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Kevin McClatchy | |||||||||
| Trustee (Thru 8/2017) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Michele V McNeill PharmD | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Edward Milstein | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Cindy Rachofsky | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Vincent A Roberti | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Bill Roedy | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Raymond F Schinazi PhD | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Alan D Schwartz | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Diana L Taylor | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Kevin Frost | |||||||||
| Chief Executive Officer | 40.0 | 0.0 | Yes (X) | $582,053 | $0 | $100,140 | |||
| Bradley Jensen | |||||||||
| Assistant Treasurer, CFO | 40.0 | 0.0 | Yes (X) | $246,513 | $0 | $63,826 | |||
| John F Logan JD PhD | |||||||||
| AssT Sec, Vp, GEN COUNSEL | 40.0 | 0.0 | Yes (X) | $239,658 | $0 | $31,714 | |||
| Rowena Johnston | |||||||||
| ASST SEC, VP, RESEARCH | 40.0 | 0.0 | Yes (X) | $194,970 | $0 | $28,678 | |||
| Edward Donnelly | |||||||||
| Asst Treasurer, Controller | 40.0 | 0.0 | Yes (X) | $156,761 | $0 | $25,109 | |||
| Eric Muscatell | |||||||||
| Vice President of Development | 40.0 | 0.0 | $219,567 | $0 | $30,470 | Yes (X) | |||
| Annette Sohn | |||||||||
| Vice President, TREAT Asia PGM | 40.0 | 0.0 | $235,371 | $0 | $23,215 | Yes (X) | |||
| AnnMarie Shannahan | |||||||||
| Vice President, Public Info. | 40.0 | 0.0 | $224,984 | $0 | $30,789 | Yes (X) | |||
| Gregorio Millet | |||||||||
| Vice President, Public Policy | 40.0 | 0.0 | $187,714 | $0 | $27,819 | Yes (X) | |||
| Andrew McInness | |||||||||
| Director, Publications | 40.0 | 0.0 | $160,449 | $0 | $57,457 | Yes (X) | |||
| Anthony Ancona | |||||||||
| Vice President, Human Resource | 40.0 | 0.0 | $182,044 | $0 | $28,322 | Yes (X) | |||
| Susan Doster | |||||||||
| Chief Technology Officer | 40.0 | 0.0 | $144,866 | $0 | $46,025 | Yes (X) | |||
| Bennah Serfaty | |||||||||
| Sr Director of CommunicatiON | 40.0 | 0.0 | $127,459 | $0 | $55,087 | Yes (X) | |||
| JONATHAN KEY | |||||||||
| DIRECTOR, PHILANTHROPY | 40.0 | 0.0 | $185,023 | $0 | $48,664 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $3,087,432 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $597,315 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 25 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| AAB PRODUCTION INC | |||||
| 64 ALLEN STREET 5TH FLOOR | NEW YORK | NY | 10002 | events production | $512,500 |
| JOSH WOODS PRODUCTION | |||||
| 39 WEST 14TH STREET SUITE 504 | NEW YORK | NY | 10011 | Events Production | $394,500 |
| EIDOLON COMMUNICATIONS INC | |||||
| 15 MAIDEN LANE SUITE 1401 | NEW YORK | NY | 10038 | DIRECT MAIL/CONSULT. | $313,319 |
| King Company | |||||
| 101 FIFTH AVENUE 8TH FLOOR | NEW YORK | NY | 10003 | PUBLIC RELATIONS | $226,601 |
| CLARKEBOT INC | |||||
| 33 Fairview Terrace | MAPLEWOOD | NJ | 07040 | Art & Graphic Design | $148,788 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 10 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $207,695 | FederatedCampaignsAmt |
| Fundraising | $30,056,709 | FundraisingAmt |
| Government Grants | $11,578,196 | GovernmentGrantsAmt |
| All Other Contributions | $8,999,778 | AllOtherContributionsAmt |
| Noncash Contributions | $82,139 | NoncashContributionsAmt |
| Total Contributions | $50,842,378 | TotalContributionsAmt |
| Total Program Service Revenue | $0 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,295,049 | TotalRevenueColumnAmt |
| Exclusion | $1,295,049 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $59,464 | TotalRevenueColumnAmt |
| Exclusion | $59,464 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $11,576,947 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $11,437,468 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $139,479 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $139,479 | TotalRevenueColumnAmt |
| Exclusion | $139,479 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $1,797,050 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $30,056,709 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $13,726,531 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$11,929,481 | TotalRevenueColumnAmt |
| Exclusion | -$11,929,481 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gaming Gross Income | $0 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $0 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $13,222 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $2,268 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $10,954 | TotalRevenueColumnAmt |
| Exclusion | $10,954 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| LIST RENTALS | 900099 | $3,691 | $3,691 |
| STORE SALES | 900099 | $1,250 | $1,250 |
| MISCELLANEOUS INCOME | 900099 | $3,788 | $3,788 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $8,729 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $40,426,572 | TotalRevenueColumnAmt |
| Exclusion | -$10,415,806 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,933,673 | TotalAmt |
| Program Services | $7,933,673 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,270,602 | TotalAmt |
| Program Services | $4,270,602 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,574,035 | TotalAmt |
| Program Services | $1,873,359 | ProgramServicesAmt |
| Management And General | $333,721 | ManagementAndGeneralAmt |
| Fundraising | $366,955 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,071,158 | TotalAmt |
| Program Services | $4,044,015 | ProgramServicesAmt |
| Management And General | $651,731 | ManagementAndGeneralAmt |
| Fundraising | $1,375,412 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $353,056 | TotalAmt |
| Program Services | $226,100 | ProgramServicesAmt |
| Management And General | $40,805 | ManagementAndGeneralAmt |
| Fundraising | $86,151 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,577,997 | TotalAmt |
| Program Services | $1,028,659 | ProgramServicesAmt |
| Management And General | $240,615 | ManagementAndGeneralAmt |
| Fundraising | $308,723 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $526,328 | TotalAmt |
| Program Services | $344,477 | ProgramServicesAmt |
| Management And General | $62,905 | ManagementAndGeneralAmt |
| Fundraising | $118,946 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $550,339 | TotalAmt |
| Program Services | $547,250 | ProgramServicesAmt |
| Management And General | $3,058 | ManagementAndGeneralAmt |
| Fundraising | $31 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $199,289 | TotalAmt |
| Management And General | $199,289 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $105,279 | TotalAmt |
| Program Services | $105,279 | ProgramServicesAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $746,863 | TotalAmt |
| Fundraising | $746,863 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $304,037 | TotalAmt |
| Management And General | $304,037 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,513,792 | TotalAmt |
| Program Services | $1,002,108 | ProgramServicesAmt |
| Management And General | $46,649 | ManagementAndGeneralAmt |
| Fundraising | $465,035 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $374,969 | TotalAmt |
| Program Services | $347,418 | ProgramServicesAmt |
| Management And General | $1,088 | ManagementAndGeneralAmt |
| Fundraising | $26,463 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $74,432 | TotalAmt |
| Program Services | $47,696 | ProgramServicesAmt |
| Management And General | $6,182 | ManagementAndGeneralAmt |
| Fundraising | $20,554 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $297,330 | TotalAmt |
| Program Services | $237,284 | ProgramServicesAmt |
| Management And General | $27,409 | ManagementAndGeneralAmt |
| Fundraising | $32,637 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,368,172 | TotalAmt |
| Program Services | $1,070,432 | ProgramServicesAmt |
| Management And General | $122,466 | ManagementAndGeneralAmt |
| Fundraising | $175,274 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,167,732 | TotalAmt |
| Program Services | $561,630 | ProgramServicesAmt |
| Management And General | $6,006 | ManagementAndGeneralAmt |
| Fundraising | $600,096 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $775,959 | TotalAmt |
| Program Services | $706,912 | ProgramServicesAmt |
| Management And General | $10,019 | ManagementAndGeneralAmt |
| Fundraising | $59,028 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $542,084 | TotalAmt |
| Program Services | $430,415 | ProgramServicesAmt |
| Management And General | $49,243 | ManagementAndGeneralAmt |
| Fundraising | $62,426 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $326,133 | TotalAmt |
| Program Services | $258,950 | ProgramServicesAmt |
| Management And General | $29,626 | ManagementAndGeneralAmt |
| Fundraising | $37,557 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| PROGRAM MATERIALS | $7,088,724 | $7,088,724 | ||
| PROGRAM TECHNICAL SUPPORT | $998,963 | $998,963 | ||
| POSTAGE & SHIPPING | $682,917 | $342,399 | $2,911 | $337,607 |
| PRINTING | $669,627 | $200,795 | $968 | $467,864 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,153,893 | TotalAmt |
| Program Services | $1,198,412 | ProgramServicesAmt |
| Management And General | $544,995 | ManagementAndGeneralAmt |
| Fundraising | $410,486 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $43,247,383 | TotalAmt |
| Program Services | $34,865,552 | ProgramServicesAmt |
| Management And General | $2,683,723 | ManagementAndGeneralAmt |
| Fundraising | $5,698,108 | FundraisingAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Joint Costs | Yes (X) | JointCostsInd |
Total Joint Costs TotalJointCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $713,656 | TotalAmt |
| Program Services | $225,466 | ProgramServicesAmt |
| Fundraising | $488,190 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $21,651,323 | BOYAmt |
| EOY | $9,608,338 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $323,338 | BOYAmt |
| EOY | $323,338 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $464,693 | BOYAmt |
| EOY | $1,054,693 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,959,486 | BOYAmt |
| EOY | $7,565,297 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $575,913 | BOYAmt |
| EOY | $444,076 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,630,566 | BOYAmt |
| EOY | $2,895,192 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $7,508,100 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $4,433,600 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,976,566 | BOYAmt |
| EOY | $3,074,500 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $42,064,454 | BOYAmt |
| EOY | $53,762,394 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $36,797 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,090,525 | BOYAmt |
| EOY | $1,493,892 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $80,773,661 | BOYAmt |
| EOY | $80,221,720 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,412,592 | BOYAmt |
| EOY | $3,028,826 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,973,966 | BOYAmt |
| EOY | $3,445,162 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,727,662 | BOYAmt |
| EOY | $11,985,013 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,020,261 | BOYAmt |
| EOY | $2,032,473 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $19,134,481 | BOYAmt |
| EOY | $20,491,474 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $58,215,899 | BOYAmt |
| EOY | $55,835,428 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,060,748 | BOYAmt |
| EOY | $3,526,335 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $362,533 | BOYAmt |
| EOY | $368,483 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $61,639,180 | BOYAmt |
| EOY | $59,730,246 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $80,773,661 | BOYAmt |
| EOY | $80,221,720 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$2,820,811 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $911,877 | NetUnrlzdGainsLossesInvstAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $38,582,579 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $57,556,516 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $56,251,128 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $58,810,206 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $50,842,378 | CurrentTaxYearAmt |
| Total | $262,042,807 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $38,582,579 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $57,556,516 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $56,251,128 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $58,810,206 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $50,842,378 | CurrentTaxYearAmt |
| Total | $262,042,807 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $2,261,396 | SubstantialContributorsTotAmt |
| Public Support Total170 | $259,781,411 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $755,293 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $804,366 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,652,775 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,316,372 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,354,513 | CurrentTaxYearAmt |
| Total | $5,883,319 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,467,184 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,693,833 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $2,103,589 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,246,081 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,819,001 | CurrentTaxYearAmt |
| Total | $9,329,688 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $277,255,814 | TotalSupportAmt |
| Public Support CY170 | 0.93697 | PublicSupportCY170Pct |
| Public Support PY170 | 0.92039 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
| Thirty Thr Pct Suprt Tests PY170 | Yes (X) | ThirtyThrPctSuprtTestsPY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | false | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | false | DirectContactLegislatorsInd |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | Yes (true) | OtherActivitiesInd |
| Other Activities | $371,694 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $371,694 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
| Form4720 Filed4912 Tax | false | Form4720Filed4912TaxInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | LOBBYING EXPENSES | FormAndLineReferenceDesc |
| Explanation | PART II-B THE FOUNDATION FOR AIDS RESEARCH DEVELOPED AN ACTION AGENDA TO END AIDS THAT IDENTIFIED CRITICAL DECISIONS THAT NEED TO BE MADE TO ADVANCE EVIDENCE BASED AIDS POLICIES. WE CREATED A VARIETY OF ISSUE BRIEFS ON TOPICS SUCH AS THE POTENTIAL IMPACT OF VARIOUS BUDGET SCENARIOS ON GLOBAL HEALTH SERVICES, AND POLICY PRIORITIES TO ADDRESS THE HIV EPIDEMIC AMONG GAY MEN IN THE US. THESE ISSUE BRIEFS WERE SHARED WITH CAPITOL HILL STAFF AND MEMBERS OF THE ADMINISTRATION. AMFAR MET REGULARLY WITH STAFF TO MEMBERS OF CONGRESS AND WITH ADMINISTRATION STAFF, AND WE PROVIDED INPUT TO THE ADMINISTRATION ON DEVELOPMENT OF THE PEPFAR BLUEPRINT FOR AN AIDS FREE GENERATION. AMFAR SPONSORED SEVERAL BRIEFINGS ON CAPITOL HILL ON AIDS POLICY AND RESEARCH ISSUES. AMFAR USES THESE BRIEFINGS AS AN EDUCATIONAL TOOL. | ExplanationTxt |
Schedule D IRS990ScheduleD
Art Public Exhibition Amounts ArtPublicExhibitionAmountsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Assets Included | $494,473 | AssetsIncludedAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Held Works Art | HeldWorksArtGrp |
Collection Used Other Purposes CollectionUsedOtherPurposesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Collection Used Other Purposes | Yes (X) | CollectionUsedOtherPurposesInd |
| Other Purposes | Donated Items, Inventory etc. | OtherPurposesDesc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Solicited Assets Sale | Yes (true) | SolicitedAssetsSaleInd |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $541,231 | BeginningYearBalanceAmt |
| Contributions | $5,950 | ContributionsAmt |
| Investment Earnings Or Losses | $45,952 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $593,133 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $493,036 | BeginningYearBalanceAmt |
| Contributions | $7,293 | ContributionsAmt |
| Investment Earnings Or Losses | $40,902 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $541,231 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $490,979 | BeginningYearBalanceAmt |
| Contributions | $7,998 | ContributionsAmt |
| Investment Earnings Or Losses | -$5,941 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $493,036 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $443,886 | BeginningYearBalanceAmt |
| Contributions | $6,543 | ContributionsAmt |
| Investment Earnings Or Losses | $40,550 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $490,979 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $520,804 | BeginningYearBalanceAmt |
| Contributions | $3,211 | ContributionsAmt |
| Investment Earnings Or Losses | $20,742 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $100,871 | OtherExpendituresAmt |
| End Year Balance | $443,886 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prmnnt Endowment Balance EOY | 0.62120 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.37880 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
| Land | LandGrp | |
| Buildings | BuildingsGrp |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $2,542,490 | OtherCostOrOtherBasisAmt |
| Depreciation | $0 | DepreciationAmt |
| Book Value | $2,542,490 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $304,826 | OtherCostOrOtherBasisAmt |
| Depreciation | $0 | DepreciationAmt |
| Book Value | $304,826 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $4,660,784 | OtherCostOrOtherBasisAmt |
| Depreciation | $4,433,600 | DepreciationAmt |
| Book Value | $227,184 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $3,074,500 | TotalBookValueLandBuildingsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| LONG TERM LEASE LIABILITY | $1,810,442 |
| SECTION 457 RETIREMENT LIABILITY | $222,031 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $2,032,473 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $41,557,266 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $911,877 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $218,817 | DonatedServicesAndUseFcltsAmt |
| Revenue Not Reported | $1,130,694 | RevenueNotReportedAmt |
| Revenue Subtotal | $40,426,572 | RevenueSubtotalAmt |
| Total Revenue Per Form990 | $40,426,572 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $43,466,200 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $218,817 | DonatedServicesUseFcltsAmt |
| Expenses Not Reported | $218,817 | ExpensesNotReportedAmt |
| Expenses Subtotal | $43,247,383 | ExpensesSubtotalAmt |
| Total Expenses Per Form990 | $43,247,383 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| ENDOWMENTS | PART V, LINE 4 AMFAR'S ENDOWMENT FUND IS INTENDED TO FUND THE VARIOUS GENERAL RESEARCH PROGRAMS THE ORGANIZATION SPONSORS. |
| FIN 48 - INCOME TAXES | AMFAR FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND GUIDANCE ON MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS "MORE-LIKELY-THAN-NOT" TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. AMFAR IS EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3), THOUGH IT IS SUBJECT TO TAX ON INCOME UNRELATED TO ITS EXEMPT PURPOSE, UNLESS THAT INCOME IS OTHERWISE EXCLUDED BY THE CODE. AMFAR HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT WAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. AMFAR HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. |
| COLLECTIONS OF ART, HISTORICAL TREASURES, OR OTHER SIMILAR ASSETS | PART III, LINE 4 AMFAR HOLDS VARIOUS ITEMS OF JEWELRY, PHOTOGRAPHS AND OTHER ITEMS OF ARTISTIC VALUE THAT HAVE BEEN DONATED TO THE ORGANIZATION FOR SALE AT SPECIAL EVENTS. THE ORGANIZATION HAS MAINTAINED THESE ITEMS IN INVENTORY FOR A FEW YEARS AND IS IN THE PROCESS OF SELLING THEM. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (11 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt | OfficesOfficesCnt | EmployeeEmployeeCnt |
|---|---|---|---|---|---|
| Central America and the Caribbean | Grantmaking | N/A | $49,800 | ||
| East Asia and the Pacific | Grantmaking | N/A | $2,719,032 | ||
| Europe (Including Iceland and Greenland) | Grantmaking | N/A | $996,920 | ||
| North America | Grantmaking | N/A | $154,467 | ||
| South America | Grantmaking | N/A | $240,386 | ||
| South Asia | Grantmaking | N/A | $32,811 | ||
| Sub-Saharan Africa | Grantmaking | N/A | $77,187 | ||
| East Asia and the Pacific | Program Services | THERAPEUTICS,TRAINING | $1,731,815 | 1 | 17 |
| East Asia and the Pacific | Fundraising | N/A | $1,820,696 | ||
| Europe (Including Iceland and Greenland) | Fundraising | N/A | $8,386,928 | ||
| South America | Fundraising | N/A | $769,244 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 1 | SubtotalOfficesCnt |
| Subtotal Employees | 17 | SubtotalEmployeesCnt |
| Total Office | 1 | TotalOfficeCnt |
| Total Employee | 17 | TotalEmployeeCnt |
| Subtotal Spent | $16,979,286 | SubtotalSpentAmt |
| Total Spent | $16,979,286 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (98 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| Caribbean/Central America | GMT INITIATIVE AWARDS | $25,000 | wire transfe |
| Caribbean/Central America | GMT INITIATIVE AWARDS | $23,000 | wire transfe |
| East Asia/Pacific | BASIC RESEARCH | $23,619 | wire transfe |
| East Asia/Pacific | BASIC RESEARCH | $499,920 | wire transfe |
| East Asia/Pacific | BASIC RESEARCH | $56,378 | wire transfe |
| East Asia/Pacific | BASIC RESEARCH | $74,988 | wire transfe |
| East Asia/Pacific | GMT INITIATIVE GRANTS | $184,620 | wire transfe |
| East Asia/Pacific | GMT INITIATIVE GRANTS | $39,814 | wire transfe |
| East Asia/Pacific | GMT INITIATIVE AWARDS | $25,000 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,893 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $7,062 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $24,984 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $7,500 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $7,500 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $25,000 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $10,346 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,396 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $18,400 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,622 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $12,197 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $19,982 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $14,025 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $15,650 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $9,950 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $21,044 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $16,800 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $21,814 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $23,714 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $22,488 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $22,744 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $23,670 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $21,510 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $22,570 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $14,200 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $22,280 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $21,192 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $21,234 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,175 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,375 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,075 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,475 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,550 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,250 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $243,968 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $175,225 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $130,587 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $9,000 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $197,244 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $63,024 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $41,632 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $46,216 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $8,206 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $9,450 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $10,046 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $11,575 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $11,048 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,242 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $18,423 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $7,283 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $13,254 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,966 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $7,961 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $62,496 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $18,682 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $16,789 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $9,823 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $7,972 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,500 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,497 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,500 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,500 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $6,260 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $18,750 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,625 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,625 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,625 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,625 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $5,625 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $15,000 | wire transfe |
| Europe | BASIC RESEARCH | $29,990 | wire transfe |
| Europe | BASIC RESEARCH | $53,332 | wire transfe |
| Europe | BASIC RESEARCH | $20,833 | wire transfe |
| Europe | BASIC RESEARCH | $75,000 | wire transfe |
| Europe | BASIC RESEARCH | $96,645 | wire transfe |
| Europe | BASIC RESEARCH | $90,009 | wire transfe |
| Europe | RESEARCH RSRL | $182,141 | wire transfe |
| Europe | RESEARCH RSRL | $143,824 | wire transfe |
| Europe | RESEARCH RSRL | $316,203 | wire transfe |
| North America (excl USA) | BASIC RESEARCH | $54,469 | wire transfe |
| North America (excl USA) | BASIC RESEARCH | $99,998 | wire transfe |
| South America | BASIC RESEARCH | $15,000 | wire transfe |
| South America | GMT INITIATIVE GRANTS | $200,386 | wire transfe |
| South America | GMT INITIATIVE AWARDS | $25,000 | wire transfe |
| South Asia | TREAT ASIA | $7,500 | wire transfe |
| South Asia | TREAT ASIA | $16,912 | wire transfe |
| South Asia | TREAT ASIA | $8,399 | wire transfe |
| Sub-Saharan Africa | GMT INITIATIVE AWARDS | $25,000 | wire transfe |
| Sub-Saharan Africa | TREAT ASIA | $51,325 | wire transfe |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 98 | Total501c3OrgCnt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | false | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FOREIGN ACTIVITIES | PART I, LINE 2 INTERNATIONAL ORGANIZATIONS ARE RECOMMENDED FOR FUNDING BASED UPON THE RESULTS OF COMMUNITY-BASED PEER REVIEW AND/OR PROGRAM STAFF ASSESSMENT OF PROPOSAL MERIT AND ORGANIZATION CAPACITY TO UNDERTAKE PROPOSED PROJECTS THAT ARE CHARITABLE IN PURPOSE. PRE-AWARD DUE-DILIGENCE FOR NEW INTERNATIONAL GRANTEES INCLUDES REVIEW OF ORGANIZATION DOCUMENTS AND REGISTRATIONS TO VERIFY THAT THE ORGANIZATION OPERATES FOR A CHARITABLE PURPOSE AND THAT BASIC CAPACITY FOR PROJECT OVERSIGHT AND GOVERNANCE HAS BEEN ESTABLISHED. ALL INTERNATIONAL GRANTEES ARE REQUIRED TO REPORT SEMI-ANNUALLY ON PROJECT PROGRESS AND EXPENDITURES; CONTINUED REPORTING IS REQUIRED UNTIL SUCH TIME AS GRANT FUNDS ARE EXPENDED IN FULL. REPORTS ARE REVIEWED BY ADMINISTRATIVE AND PROGRAM STAFF. ADDITIONAL OVERSIGHT IS PROVIDED AS NECESSARY BY MEANS OF ONGOING, INFORMAL CONTACT WITH SITES REGARDING PROGRESS AND TECHNICAL ISSUES AND SITE VISITS WHERE FEASIBLE. INTERNATIONAL RESEARCH GRANT RECIPIENTS SUBMIT AN INTERIM AND A FINAL PROGRESS REPORTING ADDITION TO EXPENDITURES REPORTS DUE FOLLOWING THE ENDS OF THE 2ND, 3RD AND FINAL QUARTERS OF THE PERFORMANCE PERIOD. |
| FOREIGN ACTIVITIES | PART I, LINE 3, COLUMN D THE FOUNDATION FOR AIDS RESEARCH CONDUCTS MANY OF ITS GRANT-MAKING PROGRAM SERVICES (SEE PART III OF FORM 990) IN U.S. AND FOREIGN JURISDICTIONS. IN COLUMN D, THE ORGANIZATION HAS REPORTED THE BASIC PROGRAM THESE GRANTS SUPPORT; PLEASE REFER TO PART III FOR MORE INFORMATION ABOUT THESE PROGRAMS/INITIATIVES. |
| FOREIGN ACTIVITIES - STATUS OF GRANTEES | THE FOUNDATION FOR AIDS RESEARCH SUPPORTS MANY NON-U.S. ORGANIZATIONS IN THE FIGHT AGAINST AIDS AND HIV-RELATED DISEASES. FOR PURPOSES OF SCHEDULE F, PART II, LINE 2 - ALL 98 CHARITIES SUPPORTED ARE PRESUMED TO BE THE EQUIVALENT OF U.S. CHARITIES. |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| Phone Solicitations | Yes (X) | PhoneSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Solicitation Of Govt Grants | Yes (X) | SolicitationOfGovtGrantsInd |
| Special Fundraising Events | Yes (X) | SpecialFundraisingEventsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp (4 entries)
| ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd | Gross ReceiptsGrossReceiptsAmt | Retained By ContractorRetainedByContractorAmt | Net To OrganizationNetToOrganizationAmt |
|---|---|---|---|---|
| aab productions INC | ||||
| events production | false | $22,385,427 | $586,480 | $21,798,947 |
| EIDOLON COMM INC | ||||
| direct mail | false | $2,149,452 | $288,370 | $1,861,082 |
| Donor Services Group LLC | ||||
| Tele marketing | false | $7,838 | $31,738 | -$23,900 |
| Josh Woods Production | ||||
| events Production | false | $4,895,395 | $359,850 | $4,535,545 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $29,438,112 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $1,266,438 | TotalRetainedByContractorsAmt |
| Total Net To Organization | $28,171,674 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | DC | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | TX | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | Cannes | Event1Nm |
| Gross Receipts Event1 | $16,271,745 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $15,787,745 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $484,000 | GrossRevenueEvent1Amt |
| Rent Facility Costs Event1 | $988,368 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $299,106 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $2,675,173 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $3,084,555 | OtherDirectExpensesEvent1Amt |
| Event2 | Dallas | Event2Nm |
| Gross Receipts Event2 | $4,406,737 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $4,223,737 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $183,000 | GrossRevenueEvent2Amt |
| Rent Facility Costs Event2 | $341,192 | RentFacilityCostsEvent2Amt |
| Food And Beverage Event2 | $229,411 | FoodAndBeverageEvent2Amt |
| Entertainment Event2 | $162,780 | EntertainmentEvent2Amt |
| Other Direct Expenses Event2 | $647,270 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 17 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $11,175,277 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $10,045,227 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $1,130,050 | GrossRevenueOtherEventsAmt |
| Rent Fclty Costs Other Events | $682,192 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $847,590 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $1,264,605 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $2,504,289 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $31,853,759 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $30,056,709 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $1,797,050 | GrossRevenueTotalEventsAmt |
| Rent Fclty Costs Total Events | $2,011,752 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $1,376,107 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $4,102,558 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $6,236,114 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $13,726,531 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$11,929,481 | NetIncomeSummaryAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE G, PART I | FormAndLineReferenceDesc |
| Explanation | THE FOUNDATION FOR AIDS RESEARCH ACTUALLY PAID OUT $746,863 IN FUNDRAISING EXPENSES FOR THE YEAR ENDING SEPTEMBER 30, 2017. THIS AMOUNT IS REPORTED ON PART IX, LINE 11(E). FOR PURPOSES OF SCHEDULE G, THE FOUNDATION IS REPORTING ALL AMOUNTS PAID TO THE CONSULTANTS LISTED ON PART I, REGARDLESS OF WHETHER SUCH AMOUNTS WERE PURE FUNDRAISING EXPENSES OR EVENT PRODUCTION COSTS. ON SCHEDULE G, THE TOTAL AMOUNT PAID TO THE ORGANIZATIONS LISTED IS $1,266,438. OF THAT $1,266,438, ONLY $746,863 WAS PAID FOR FUNDRAISING SERVICES, THE REMAINING $519,575 WAS PAID FOR EVENT PRODUCTION SERVICES. IN THE INTERESTS OF CLARITY, THE FOUNDATION WOULD ALSO LIKE TO MAKE CLEAR THAT THE COMPENSATION REPORTED AS HAVING BEEN PAID TO THE PROFESSIONAL FUNDRAISERS REPORTED ON SCHEDULE G IS REPORTED ON A FISCAL YEAR BASIS. SOME OF THOSE SAME FUNDRAISERS ARE REPORTED ON THE FOUNDATION'S TOP 5 HIGHEST PAID INDEPENDENT CONTRACTORS LIST (IN SCHEDULE O). IN COMPLIANCE WITH THE INSTRUCTIONS TO THE FORM 990, COMPENSATION REPORTED FOR PART VII (AND LISTED IN SCHEDULE O) IS REPORTED ON A CALENDAR YEAR BASIS. ACCORDINGLY, AMOUNTS ON PART VII AND SCHEDULE G WILL NOT RECONCILE. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (57 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| University of Washington | |||||||
| 4333 Brooklyn Ave NE Box 359472 | Seattle | WA | 981959472 | 916001537 | 501(c)(3) | $22,500 | BASIC RESEARCH |
| Oregon Health and Science University | |||||||
| 3181 SW Sam Jackson Park Road | Portland | OR | 97239 | 931176109 | 501(c)(3) | $29,970 | BASIC RESEARCH |
| Emory University | |||||||
| 1599 Clifton Rd | Atlanta | GA | 303224250 | 580566256 | 501(c)(3) | $29,999 | BASIC RESEARCH |
| Blood Systems Inc | |||||||
| 270 Masonic Avenue | San Francisco | CA | 941184417 | 860098929 | 501(c)(3) | $30,000 | BASIC RESEARCH |
| University of Utah | |||||||
| 15 North Medical Drive East JMRB 21 | Salt Lake City | UT | 841125650 | 876000525 | 501(c)(3) | $30,000 | BASIC RESEARCH |
| Regents of the University of CA San Fran | |||||||
| 3333 California Street Suite 315 | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $51,432 | BASIC RESEARCH |
| University of Nebraska-Lincoln | |||||||
| 151 Whittier Research Center 2200 | Lincoln | NE | 685830861 | 470049123 | 501(c)(3) | $30,000 | BASIC RESEARCH |
| The Rockefeller University | |||||||
| 1230 York Avenue | New York | NY | 10065 | 131624158 | 501(c)(3) | $93,750 | BASIC RESEARCH |
| The George Washington University | |||||||
| 2121 I Street NW Suite 601 | Washington | DC | 20052 | 530196584 | 501(c)(3) | $67,495 | BASIC RESEARCH |
| Beth Israel Deaconess Medical Center | |||||||
| 330 Brookline Avenue | Boston | MA | 02215 | 042103881 | 501(c)(3) | $497,988 | BASIC RESEARCH |
| Regents of the University of Ca San Fran | |||||||
| 3333 California Street Suite 315 | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $500,072 | BASIC RESEARCH |
| University of California San Diego | |||||||
| 9500 Gilman Drive | San Diego | CA | 920930679 | 956006144 | 501(c)(3) | $100,001 | BASIC RESEARCH |
| Case Western Reserve University | |||||||
| 10900 Euclid Avenue LC 4930 | Cleveland | OH | 44106 | 341018992 | 501(c)(3) | $100,001 | BASIC RESEARCH |
| Case Western Reserve University | |||||||
| 10900 Euclid Avenue LC 4930 | Cleveland | OH | 44106 | 341018992 | 501(c)(3) | $100,001 | BASIC RESEARCH |
| Emory University | |||||||
| 1599 Clifton Rd | Atlanta | GA | 303224250 | 580566256 | 501(c)(3) | $100,001 | BASIC RESEARCH |
| Emory University | |||||||
| 1599 Clifton Road | Atlanta | GA | 303224250 | 580566256 | 501(c)(3) | $100,001 | BASIC RESEARCH |
| Johns Hopkins University | |||||||
| 733 N Broadway MRB Suite 117 | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $100,001 | BASIC RESEARCH |
| Regents of the University of CA San Fran | |||||||
| 3333 California Street Suite 315 | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $19,440 | BASIC RESEARCH |
| Boston Medical Center | |||||||
| One Boston Medical Center Place | Boston | MA | 02118 | 043314093 | 501(c)(3) | $75,000 | BASIC RESEARCH |
| Yale University | |||||||
| 266 Whitney Ave | New Haven | CT | 06511 | 060646973 | 501(c)(3) | $12,500 | BASIC RESEARCH |
| Emory University | |||||||
| 1599 Clifton Road | Atlanta | GA | 303224250 | 580566256 | 501(c)(3) | $50,000 | BASIC RESEARCH |
| The Rockefeller University | |||||||
| 1230 York Avenue | New York | NY | 10065 | 131624158 | 501(c)(3) | $60,000 | BASIC RESEARCH |
| The Rockefeller University | |||||||
| 1230 York Avenue | New York | NY | 10065 | 131624158 | 501(c)(3) | $168,790 | BASIC RESEARCH |
| Fdn For the National Institutes of Health | |||||||
| 9650 Rockville Pike | Bethesda | MD | 208143999 | 521986675 | 501(c)(3) | $133,334 | BASIC RESEARCH |
| University of California San Francisco | |||||||
| 3333 California Street Suite 315 | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $100,000 | BASIC RESEARCH |
| University of Washington | |||||||
| 4333 Brooklyn Avenue NE Box 35947 | Seattle | WA | 981959472 | 916001537 | 501(c)(3) | $133,333 | BASIC RESEARCH |
| Yale University | |||||||
| 266 Whitney Ave | New Haven | CT | 06511 | 060646973 | 501(c)(3) | $133,334 | BASIC RESEARCH |
| University of Massachusetts Medical School | |||||||
| 373 Plantation Street | Worcester | MA | 016052377 | 043167352 | 501(c)(3) | $133,334 | BASIC RESEARCH |
| Johns Hopkins University | |||||||
| 733 N Broadway MRB Suite 117 | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $132,962 | BASIC RESEARCH |
| The J David Gladstone Institutes | |||||||
| 1650 Owens Street | San Francisco | CA | 94158 | 237203666 | 501(c)(3) | $75,000 | BASIC RESEARCH |
| The J David Gladstone Institutes | |||||||
| 1650 Owens Street | San Francisco | CA | 94158 | 237203666 | 501(c)(3) | $75,000 | BASIC RESEARCH |
| Columbia University | |||||||
| 630 West 168th St Box 49 | New York | NY | 10032 | 135598093 | 501(c)(3) | $74,523 | BASIC RESEARCH |
| Boston Children's Hospital | |||||||
| 3 Blackfan Circle Room 3082 | Boston | MA | 02115 | 042774441 | 501(c)(3) | $68,565 | BASIC RESEARCH |
| University of Washington | |||||||
| 4333 Brooklyn Avenue NE Box 35947 | Seattle | WA | 981959472 | 916001537 | 501(c)(3) | $99,989 | BASIC RESEARCH |
| University of California Los Angeles | |||||||
| 11000 Kinross Avenue Suite 211 | Los Angeles | CA | 90095 | 956006143 | 501(c)(3) | $100,000 | BASIC RESEARCH |
| Trustees of the University of Pennsylvania | |||||||
| 3451 Walnut Street P-221 Franklin | Philadelphia | PA | 191046250 | 231352685 | 501(c)(3) | $100,000 | BASIC RESEARCH |
| Mayo Clinic College of Medicine | |||||||
| 200 First Street SW | Rochester | MN | 55905 | 416011702 | 501(c)(3) | $25,000 | BASIC RESEARCH |
| Oregon Health and Science University | |||||||
| 3181 SW Sam Jackson Park Road | Portland | OR | 97239 | 931176109 | 501(c)(3) | $24,993 | BASIC RESEARCH |
| Boston University School of Medicine | |||||||
| 650 Albany St EBRC 640 | Boston | MA | 02118 | 043314093 | 501(c)(3) | $24,999 | BASIC RESEARCH |
| The George Washington University | |||||||
| 2121 I Street NW Suite 601 | Washington | DC | 200520086 | 530196584 | 501(c)(3) | $24,999 | BASIC RESEARCH |
| Fred Hutchinson Cancer Research Center | |||||||
| 1100 Fairview Ave N | Seattle | WA | 98109 | 237156071 | 501(c)(3) | $24,999 | BASIC RESEARCH |
| University of Maryland at Baltimore | |||||||
| 725 Lombard Street Room S615 | Baltimore | MD | 21201 | 526002033 | 501(c)(3) | $25,000 | BASIC RESEARCH |
| Fred Hutchinson Cancer Research Center | |||||||
| 1100 Fairview Ave N | Seattle | WA | 98109 | 237156071 | 501(c)(3) | $24,999 | BASIC RESEARCH |
| International AIDS Vaccine Initiative | |||||||
| 125 Broad Street 9th Floor | New York | NY | 10004 | 133870223 | 501(c)(3) | $24,921 | BASIC RESEARCH |
| Swarthmore College | |||||||
| 500 College Avenue | Swarthmore | PA | 19081 | 231352683 | 501(c)(3) | $13,333 | BASIC RESEARCH |
| Johns Hopkins University | |||||||
| 733 N Broadway MRB Suite 117 | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $190,885 | GMT INITIATIVE GRANTS |
| New Venture Fund | |||||||
| 120 Connecticut Avenue NW Ste 300 | Washington | DC | 20036 | 205806345 | 501(c)(3) | $200,000 | PREVENTION SCIENCE OUTREACH |
| New Venture Fund | |||||||
| 1201 Connecticut Avenue NW Suite 30 | Washington | DC | 20036 | 205806345 | 501(c)(3) | $300,000 | PREVENTION SCIENCE OUTREACH |
| Johns Hopkins University | |||||||
| 733 N Broadway MRB Suite 117 | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $20,000 | PUBLIC POLICY |
| Georgetown University | |||||||
| 600 New Jersey Avenue | Washington | DC | 20057 | 530196603 | 501(c)(3) | $47,928 | PUBLIC POLICY |
| AIDS Vaccine Advocacy Coalition (AVAC) | |||||||
| 423 West 127 street 4 floor | NY | NY | 10027 | 943240841 | 501(c)(3) | $49,999 | PUBLIC POLICY |
| Johns Hopkins University | |||||||
| 733 N Broadway MRB Suite 117 | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $99,942 | PUBLIC POLICY |
| University of California San Francisco | |||||||
| 3333 California Street Suite 315 | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $2,773,654 | RESEARCH RSRL |
| Harvard University | |||||||
| 29 Oxford Street | Cambridge | MA | 02138 | 042103580 | 501(c)(3) | $210,652 | RESEARCH RSRL |
| Regents of the University of Minnesota | |||||||
| 200 Oak Street SE Suite 450 | Minneapolis | MN | 554552070 | 416007513 | 501(c)(3) | $76,800 | RESEARCH RSRL |
| Johns Hopkins University | |||||||
| 733 N Broadway MRB Suite 117 | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $121,644 | TREAT ASIA |
| Massachusetts General Hospital | |||||||
| 101 Huntington Ave Suite 300 | Boston | MA | 02199 | 042697983 | 501(c)(3) | $45,000 | TREAT ASIA |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 57 | Total501c3OrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | GRANTS AND ASSISTANCE | FormAndLineReferenceDesc |
| Explanation | PART I, LINE 2 AMFAR PROVIDES GRANTS AND FELLOWSHIPS TO INDEPENDENT NOT-FOR-PROFIT ORGANIZATIONS THROUGH A PEER-REVIEW PROCESS. GRANT APPLICATIONS ARE FIRST REVIEWED BY THE FOUNDATION'S VOLUNTEER SCIENTIFIC ADVISORY COMMITTEE, WHICH COMPRISES RECOGNIZED EXPERTS IN THE MEDICAL, SCIENTIFIC, AND SOCIAL SCIENCES DISCIPLINES RELEVANT TO HIV AND AIDS. THE SCIENTIFIC ADVISORY COMMITTEE THEN SENDS ITS EVALUATIONS TO ONE OF THE THREE COMMITTEES (RESEARCH, GLOBAL INITIATIVES OR PUBLIC POLICY) OF THE FOUNDATION'S PROGRAM BOARD, WHICH SERVES IN AN ADVISORY CAPACITY TO THE BOARD OF TRUSTEES. AFTER A PROGRAM COMMITTEE HAS COMPLETED ITS REVIEW OF THE APPLICATIONS, IT PRESENTS ITS FUNDING RECOMMENDATIONS TO AMFAR'S EXECUTIVE COMMITTEE AND/OR THE FULL BOARD OF TRUSTEES FOR FINAL APPROVAL AND FUNDING AUTHORIZATION. GRANTS AND FELLOWSHIPS ARE PAYABLE OVER A ONE-TO-THREE-YEAR PERIOD, AND ARE REVOCABLE AT AMFAR'S OPTION IF THE RECIPIENT'S PERFORMANCE OR USE OF FUNDS IS NOT CONSISTENT WITH THE TERMS OF THE GRANT OR FELLOWSHIPS. IN CERTAIN CASES, THE ACTUAL AMOUNTS PAID UNDER GRANTS AND FELLOWSHIP AWARDS MAY BE LESS THAN THE ORIGINAL AWARD IF THE RECIPIENT DOES NOT USE THE FULL AMOUNT AWARDED. THEREFORE, A RESERVE FOR UNEXPENDED GRANTS AND FELLOWSHIPS HAS BEEN RECORDED. SUBAWARDS ARE GRANTS AWARDED TO NOT-FOR-PROFIT ORGANIZATIONS TO SUPPORT THE COSTS OF COLLABORATION AND PARTICIPATION IN HIV/AIDS-RELATED RESEARCH PROJECTS FOR WHICH AMFAR HAS SECURED RESTRICTED FUNDS. SUBAWARDS ARE PAYABLE OVER A ONE-YEAR PERIOD, ALTHOUGH ADVANCE PAYMENTS, IN FULL OR IN PART, MAY BE ISSUED FOLLOWING EXECUTION OF THE SUBAWARD AGREEMENT. SUBAWARDS ARE CONTINGENT UPON THE AVAILABILITY OF FUNDS AND ARE REVOCABLE IF THE RECIPIENTS' PERFORMANCE OR USE OF FUNDS IS NOT CONSISTENT WITH THE SUBAWARD TERMS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kevin Frost | ||||||||||||||
| Chief Executive Officer | $391,601 | $0 | $100,000 | $0 | $90,452 | $0 | $36,550 | $0 | $63,590 | $0 | $682,193 | $0 | $3,582 | $0 |
| Bradley Jensen | ||||||||||||||
| Assistant Treasurer, CFO | $246,513 | $0 | $0 | $0 | $0 | $0 | $17,923 | $0 | $45,903 | $0 | $310,339 | $0 | $0 | $0 |
| John F Logan JD PhD | ||||||||||||||
| AssT Sec, Vp, GEN COUNSEL | $239,658 | $0 | $0 | $0 | $0 | $0 | $16,765 | $0 | $14,949 | $0 | $271,372 | $0 | $0 | $0 |
| Rowena Johnston | ||||||||||||||
| ASST SEC, VP, RESEARCH | $194,970 | $0 | $0 | $0 | $0 | $0 | $13,729 | $0 | $14,949 | $0 | $223,648 | $0 | $0 | $0 |
| Edward Donnelly | ||||||||||||||
| Asst Treasurer, Controller | $156,761 | $0 | $0 | $0 | $0 | $0 | $11,405 | $0 | $13,704 | $0 | $181,870 | $0 | $0 | $0 |
| Eric Muscatell | ||||||||||||||
| Vice President of Development | $219,567 | $0 | $0 | $0 | $0 | $0 | $15,521 | $0 | $14,949 | $0 | $250,037 | $0 | $0 | $0 |
| Annette Sohn | ||||||||||||||
| Vice President, TREAT Asia PGM | $235,371 | $0 | $0 | $0 | $0 | $0 | $16,475 | $0 | $6,740 | $0 | $258,586 | $0 | $0 | $0 |
| AnnMarie Shannahan | ||||||||||||||
| Vice President, Public Info. | $224,984 | $0 | $0 | $0 | $0 | $0 | $15,840 | $0 | $14,949 | $0 | $255,773 | $0 | $0 | $0 |
| Gregorio Millet | ||||||||||||||
| Vice President, Public Policy | $187,714 | $0 | $0 | $0 | $0 | $0 | $13,366 | $0 | $14,453 | $0 | $215,533 | $0 | $0 | $0 |
| Andrew McInness | ||||||||||||||
| Director, Publications | $160,449 | $0 | $0 | $0 | $0 | $0 | $11,554 | $0 | $45,903 | $0 | $217,906 | $0 | $0 | $0 |
| Anthony Ancona | ||||||||||||||
| Vice President, Human Resource | $182,044 | $0 | $0 | $0 | $0 | $0 | $12,793 | $0 | $15,529 | $0 | $210,366 | $0 | $0 | $0 |
| Susan Doster | ||||||||||||||
| Chief Technology Officer | $144,866 | $0 | $0 | $0 | $0 | $0 | $10,596 | $0 | $35,429 | $0 | $190,891 | $0 | $0 | $0 |
| Bennah Serfaty | ||||||||||||||
| Sr Director of CommunicatiON | $127,459 | $0 | $0 | $0 | $0 | $0 | $9,184 | $0 | $45,903 | $0 | $182,546 | $0 | $0 | $0 |
| JONATHAN KEY | ||||||||||||||
| DIRECTOR, PHILANTHROPY | $185,023 | $0 | $0 | $0 | $0 | $0 | $13,235 | $0 | $35,429 | $0 | $233,687 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | COMPENSATION | FormAndLineReferenceDesc |
| Explanation | PART I, LINE 4 CHIEF EXECUTIVE OFFICER, KEVIN FROST, PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. IN CALENDAR YEAR 2016, AMFAR CONTRIBUTED $85,000 INTO MR. FROST'S NON-QUALIFIED RETIREMENT PLAN. THIS AMOUNT IS NOT REPORTED IN SCHEDULE J, PART II, COLUMN (C) BECAUSE THE CONTRIBUTED AMOUNT WAS DISTRIBUTED TO MR. FROST WITHIN THE SAME CALENDAR YEAR. INCLUDED IN SCHEDULE J COLUMN (B)(III) IS MR. FROST'S 2016 EMPLOYER-FUNDED 457(F) CONTRIBUTION OF $85,000 PLUS PAYOUTS OF PREVIOUSLY CONTRIBUTED EMPLOYER-FUNDED 457(F) CONTRIBUTIONS (AND EARNINGS THEREON). IN SCHEDULE J, PART II, COLUMN (F), AMFAR IS REPORTING $3,582 OF 457(F) CONTRIBUTIONS THAT WERE RECORDED AS DEFERRED COMPENSATION ON A PREVIOUSLY FILED FORM 990. | ExplanationTxt |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp | |
| Cars And Other Vehicles | CarsAndOtherVehiclesGrp | |
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 13 | ContributionCnt |
| Noncash Contributions Rpt F990 | $82,139 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | sales price | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp | |
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | FORM 990, SCHEDULE M, LINE 31 | FormAndLineReferenceDesc |
| Explanation | TO THE EXTENT THAT AMFAR RECEIVES NON-STANDARD CONTRIBUTIONS, THE ORGANIZATION'S POLICY IS TO LIQUIDATE THOSE ITEMS INTO CASH FOR EVENTUAL USE IN SUPPORT OF THE ORGANIZATION'S MISSION. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (8 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PROGRAM SERVICE ACCOMPLISHMENTS (1) | LINE 4A: RESEARCH: AMFAR SUPPORTS RESEARCH PROJECTS THAT EXPLORE NOVEL APPROACHES TO SCIENTIFICALLY SOUND BUT UNTESTED HYPOTHESES IN ALL AREAS OF RESEARCH ON HIV/AIDS, FUNDING GOAL-ORIENTED STUDIES THAT OFTEN LACK THE PRELIMINARY DATA REQUIRED FOR SUPPORT FROM TRADITIONAL GRANT MAKERS. THE FOUNDATION PLAYS A VITAL ROLE IN HIV/AIDS RESEARCH, IDENTIFYING CRITICAL GAPS IN KNOWLEDGE AND PROVIDING ESSENTIAL SEED MONEY THAT ENABLES GRANTEES AND FELLOWS TO TEST THE MERITS OF NEW CONCEPTS OR TECHNOLOGIES THAT SUBSEQUENTLY CAN BE VALIDATED THROUGH LARGE-SCALE STUDIES, SUCH AS THOSE FUNDED BY THE U.S. NATIONAL INSTITUTES OF HEALTH. AMFAR FELLOWSHIPS ALLOW TALENTED YOUNG RESEARCHERS TO CONDUCT ORIGINAL INVESTIGATIONS UNDER THE GUIDANCE OF EXPERIENCED SCIENTISTS, HELPING TO ENSURE THE LONG-TERM VITALITY OF AIDS RESEARCH. NEW GRANTS AND FELLOWSHIPS GRANTS AND FELLOWSHIPS ARE AWARDED THROUGH A RIGOROUS PROCESS OF PEER REVIEW BY A TEAM OF INDEPENDENT HIV/AIDS EXPERTS DRAWN LARGELY FROM THE VOLUNTEER SCIENTISTS ON AMFARS SCIENTIFIC ADVISORY COMMITTEE. GUIDED BY ITS SCIENTIFIC ADVISORS AND WITH THE APPROVAL OF ITS BOARD OF TRUSTEES, AMFAR PURSUES A STRATEGIC RESEARCH PLAN THAT FOCUSES ON THE PURSUIT OF A CURE FOR HIV. COUNTDOWN TO A CURE FOR AIDS IN 2015, AMFAR ANNOUNCED A $100 MILLION INVESTMENT STRATEGY TO SUPPORT ITS COUNTDOWN TO A CURE FOR AIDS INITIATIVE, WHICH IS AIMED AT DEVELOPING THE SCIENTIFIC BASIS FOR A CURE BY 2020. THE STRATEGY REPRESENTS AN UNPRECEDENTED EXPANSION OF AMFARS GRANT MAKING AND IS DESIGNED TO PROVIDE SUPPORT TO ANY SCIENTIST OR TEAM OF INVESTIGATORS FOR ANY RESEARCH IDEA WITH THE POTENTIAL TO ADVANCE THE SEARCH FOR A CURE, AT ANY STAGE OF ITS DEVELOPMENT. IT IS STRUCTURED TO PROVIDE SUSTAINED SUPPORT FOR A WIDE RANGE OF STUDIES THAT ADVANCE BOTH EMERGING AND ESTABLISHED IDEAS. THE STRATEGY COMPRISES THE FOLLOWING COMPONENTS: - AMFAR INSTITUTE FOR HIV CURE RESEARCH ESTABLISHED IN 2015 WITH A $20 MILLION GRANT OVER FIVE YEARS TO THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE INSTITUTE IS THE CORNERSTONE OF AMFARS CURE RESEARCH. - INNOVATION GRANTS THESE TWO-YEAR AWARDS OF UP TO $200,000 EACH ENABLE RESEARCHERS TO TEST INNOVATIVE IDEAS SUPPORTED BY LIMITED PRELIMINARY DATA. - IMPACT GRANTS THESE GRANTS OF UP TO $2 MILLION EACH OVER FOUR YEARS SUPPORT THE IN-DEPTH DEVELOPMENT OF CONCEPTS ALREADY UNDERPINNED BY PRELIMINARY DATA SHOWING GENUINE POTENTIAL FOR ACHIEVING A CURE. - INVESTMENT GRANTS AIMED AT RECRUITING THE EXPERIENCE AND EXPERTISE OF SCIENTISTS FROM OUTSIDE THE FIELD OF HIV, THESE $1 MILLION GRANTS ARE AWARDED OVER A FOUR-YEAR PERIOD. GRANTEES MAY HAVE EXPERTISE IN FIELDS SUCH AS CANCER, NEUROSCIENCE, OR INFLAMMATORY DISEASE THAT CAN DIRECTLY INFORM EFFORTS TO CURE HIV. - ARCHE LAUNCHED IN 2010, THE AMFAR RESEARCH CONSORTIUM ON HIV ERADICATION, OR ARCHE, SUPPORTS COLLABORATIVE TEAMS OF SCIENTISTS IN THE U.S. AND AROUND THE WORLD WORKING ON A RANGE OF HIV CURE STRATEGIES. - OPPORTUNITY FUND THIS FUNDING MECHANISM ENABLES AMFAR TO RESPOND QUICKLY TO EMERGING AND UNFORESEEN RESEARCH OPPORTUNITIES. SINCE LAUNCHING THE COUNTDOWN TO A CURE FOR AIDS INITIATIVE, AMFAR HAS AWARDED 58 COUNTDOWN GRANTS TOTALING MORE THAN $41 MILLION TO SUPPORT RESEARCH CONDUCTED BY 222 SCIENTISTS WORKING AT 74 INSTITUTIONS IN 10 COUNTRIES. INNOVATION GRANTS IN JULY 2017, AMFAR AWARDED $1.2 MILLION TO SIX RESEARCHERS WHO ARE EXPLORING MECHANISMS OF HIV PERSISTENCE AND THE POTENTIAL FOR VIRAL ERADICATION. THESE "INNOVATION" GRANTS ARE DESIGNED TO TEST AND ADVANCE PIONEERING IDEAS IN THE EARLY STAGES OF THEIR DEVELOPMENT. FOR INSTANCE, DR. ANDREW BADLEY, FROM THE MAYO CLINIC COLLEGE OF MEDICINE IN ROCHESTER, MN, WILL TEST WHETHER IXAZOMIB, A DRUG CURRENTLY USED TO TREAT THE BLOOD CANCER MULTIPLE MYELOMA, CAN REDUCE THE SIZE OF THE LATENT HIV RESERVOIR IN THE BODY, WHILE DR. JOSHUA SCHIFFER, FROM FRED HUTCHINSON CANCER RESEARCH CENTER IN SEATTLE, WILL TEST A DRUG NORMALLY USED TO PREVENT ORGAN TRANSPLANT REJECTION FOR ITS POTENTIAL TO ELIMINATE THE RESERVOIR COMPLETELY. ADDITIONALLY, DRS. ANDREW HENDERSON, FROM BOSTON UNIVERSITY SCHOOL OF MEDICINE AND FABIO ROMERIO, FROM THE UNIVERSITY OF MARYLAND IN BALTIMORE, ARE EXPLORING A CURE STRATEGY KNOWN AS "BLOCK AND LOCK", WHICH AIMS TO SILENCE HIV AND PREVENT ITS RE-EMERGENCE WHEN ANTIRETROVIRAL THERAPY IS STOPPED. AT THE GEORGE WASHINGTON UNIVERSITY IN WASHINGTON, D.C., DR. BRAD JONES AIMS TO DEVELOP A NEW CLASS OF BROADLY NEUTRALIZING ANTIBODIES TO ELIMINATE THE CONSTRAINTS CAUSED BY THE GENETIC DIFFERENCES BETWEEN PEOPLE. THE GOAL IS TO INCREASE THE NUMBER OF PEOPLE IN WHOM BROADLY NEUTRALIZING ANTIBODIES ARE ABLE TO FIND AND KILL HIV-INFECTED CELLS. AND TO BETTER UNDERSTAND HOW "THE BERLIN PATIENT" WAS CURED OF HIV, DR. BENJAMIN BURWITZ, FROM OREGON HEALTH AND SCIENCE UNIVERSITY IN PORTLAND, PLANS TO GENERATE A MONKEY MODEL LACKING THE PROTEIN CCR5, THE PRIMARY MEANS BY WHICH MOST TYPES OF HIV INFECT CELLS. BROWN WAS CURED AFTER RECEIVING A STEM CELL TRANSPLANT FROM A DONOR WITH A CCR5 MUTATION. INVESTMENT GRANTS IN FEBRUARY 2017, AMFAR ANNOUNCED A NEW ROUND OF INVESTMENT GRANTS, TOTALING $1.2 MILLION, TO SUPPORT SIX RESEARCH PROJECTS THAT ENLIST THE HELP OF BIOENGINEERS TO OVERCOME THE MAIN BARRIER TO A CURE: LATENT HIV RESERVOIRS. FOR EXAMPLE, ONE PAIR OF RESEARCHERS - DRS. TIMOTHY HENRICH, OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (UCSF), AND THE AMFAR INSTITUTE FOR HIV CURE RESEARCH, AND BIOENGINEER UTKAN DEMIRCI FROM STANFORD - AIM TO APPLY MAGNETIC LEVITATION OF SINGLE CELLS TO IDENTIFY AND CHARACTERIZE HIV RESERVOIRS. ANOTHER PAIR - DRS. HUI ZHANG AND WEIMING YANG OF JOHNS HOPKINS UNIVERSITY IN BALTIMORE - ARE USING MASS SPECTROMETRY TO IDENTIFY MOLECULES ON THE SURFACE OF CELLS THAT DIFFERENTIATE LATENT RESERVOIRS FROM UNINFECTED CELLS. AND A THIRD - DRS. PRITI KUMAR AND MARK SALTZMAN OF YALE UNIVERSITY IN NEW HAVEN, CT - ARE EXPLORING A NOVEL GENE-EDITING APPROACH USING A CELL'S MACHINERY TO ELIMINATE HIV RESERVOIRS. ARCHE (AMFAR RESEARCH CONSORTIUM ON HIV ERADICATION) IN JULY 2017, AMFAR AWARDED MORE THAN $2.3 MILLION IN ARCHE GRANTS TO SEVEN TEAMS OF RESEARCHERS WORKING ON GENE THERAPY-BASED APPROACHES TO CURING HIV. WHILE PHARMACOLOGICAL AND IMMUNOLOGICAL APPROACHES REMAIN THE DOMINANT CURE STRATEGIES, THE CASE OF THE "BERLIN PATIENT" POINTS TO THE PROMISE OF GENE THERAPY. THE GRANTEES ARE: DR. HILDEGARD BNING OF HANNOVER MEDICAL SCHOOL, GERMANY; DR. KEITH JEROME OF THE UNIVERSITY OF WASHINGTON, SEATTLE; DR. HANS-PETER KIEM OF FRED HUTCHINSON CANCER RESEARCH CENTER, SEATTLE; DR. SCOTT KITCHEN OF UCLA; DR. YASUHIRO TAKEUCHI OF UNIVERSITY COLLEGE LONDON; DR. DREW WEISSMAN OF UNIVERSITY OF PENNSYLVANIA IN PHILADELPHIA; AND DR. RICHARD WYATT OF THE SCRIPPS RESEARCH INSTITUTE IN LA JOLLA, CA. THE RESEARCHERS ARE PURSUING PROJECTS AIMED AT: DESIGNING AND REFINING VECTORS THAT CAN ACCURATELY TARGET THE CELLS THAT MAKE UP THE RESERVOIR AND REGIONS SUCH AS THE LYMPH NODES, WHERE THE RESERVOIR CELLS TEND TO BE CONCENTRATED; USING CAR T CELLS, WHICH HAVE SHOWN REMARKABLE PROMISE IN CLEARING SOME TYPES OF CANCER, AS A POTENTIAL MEANS OF KILLING HIV-INFECTED CELLS; AND EXPLORING THE POTENTIAL OF USING VIRAL AND NON-VIRAL DELIVERY MECHANISMS TO DELIVER EMERGING TYPES OF GENETIC SCISSORS THAT COULD CUT THE VIRUS OUT OF HUMAN DNA. MATHILDE KRIM FELLOWSHIPS IN OCTOBER 2016, AMFAR ANNOUNCED THE RECIPIENTS OF THE MATHILDE KRIM FELLOWSHIPS IN BASIC BIOMEDICAL RESEARCH, WHICH SUPPORT BRIGHT YOUNG SCIENTISTS SEEKING SOLUTIONS TO HIV/AIDS. THE SIX KRIM FELLOWS - DR. AMY CHUNG OF THE UNIVERSITY OF MELBOURNE IN AUSTRALIA; DR. DANIELA FERA OF BOSTON CHILDRENS HOSPITAL; DR. MARIT VAN GILS OF THE ACADEMIC MEDICAL CENTER OF THE UNIVERSITY OF AMSTERDAM IN THE NETHERLANDS; DRS. JUDD HULTQUIST AND ANAND PAI OF THE J. DAVID GLADSTONE INSTITUTES IN SAN FRANCISCO; AND DR. DANIEL ROSENBLOOM OF COLUMBIA UNIVERSITY IN NEW YORK - WERE EACH AWARDED APPROXIMATELY $150,000 OVER TWO YEARS. |
| PROGRAM SERVICE ACCOMPLISHMENTS (1) CONT. | PUBLISHED RESEARCH RESEARCH STUDIES MAKE THE GREATEST IMPACT ON THE HIV FIELD AND ON THE BROADER SCIENTIFIC COMMUNITY WHEN THEY ARE PUBLISHED IN SCIENTIFIC JOURNALS. IN FY2017, 52 SCIENTIFIC PUBLICATIONS RESULTED FROM AMFAR-FUNDED RESEARCH. EXAMPLES INCLUDE: UNDERSTANDING EXACTLY HOW THE 'BERLIN PATIENT' WAS CURED THE "BERLIN PATIENT" - TIMOTHY BROWN - REMAINS THE FIRST AND ONLY PERSON KNOWN TO HAVE BEEN CURED OF HIV. DIAGNOSED WITH LEUKEMIA, HE RECEIVED A STEM CELL TRANSPLANT FROM A DONOR WITH A RARE GENETIC MUTATION CONFERRING RESISTANCE TO HIV INFECTION. IN THE JULY 2017 ISSUE OF JAIDS, AMFAR-FUNDED SCIENTIST DR. SHARON LEWIN AND COLLEAGUES REPORTED ON THREE CASES OF HIV-INFECTED INDIVIDUALS WHO RECEIVED STEM CELL TRANSPLANTS FROM DONORS WITHOUT THE MUTATION. ALL THREE HAD UNDETECTABLE VIRAL LOADS ON ANTIRETROVIRAL THERAPY (ART) PRIOR TO THE TRANSPLANT AND WERE MAINTAINED ON ART POST-TRANSPLANT. THE NUMBER OF HIV ANTIBODIES DECREASED IN ALL OF THE PATIENTS, SUGGESTING THERE WAS LESS VIRUS. HOWEVER, IN BROWNS CASE, THE ANTIBODIES DISAPPEARED COMPLETELY. ALL THREE ALSO HAD SUBSTANTIAL REDUCTIONS IN THE SIZE OF LATENT RESERVOIRS. THE CASES CONFIRM THE ABILITY OF A STEM CELL TRANSPLANT TO PROFOUNDLY REDUCE THE SIZE OF THE HIV RESERVOIR AND THE LIKELIHOOD THAT THE MUTATION PLAYED A MAJOR ROLE IN BROWNS CURE. INJECTION OF SPECIFIC ANTIBODIES MAY REDUCE HIV VIRAL LOAD IN THE AUGUST 2017 ISSUE OF VIROLOGY, AMFAR-FUNDED SCIENTIST DR. DAN BAROUCH OF THE CENTER FOR VIROLOGY AND VACCINE RESEARCH AT BETH ISRAEL DEACONESS MEDICAL CENTER IN BOSTON AND COLLEAGUES DETAILED THEIR EXPERIMENTS USING A PASSIVE IMMUNIZATION APPROACH - INJECTING ANTIBODIES DIRECTLY INTO THE PATIENT - TO EXPLORE THE POTENTIAL ROLE OF ANTIBODIES IN CURING HIV INFECTION. BAROUCH AND ASSOCIATES TESTED TWO ANTIBODIES IN 18 MONKEYS INFECTED WITH SHIV, A COMBINATION OF HIV AND SIV (THE MONKEY FORM OF THE VIRUS). BOTH REDUCED THE VIRAL LOAD IN THE MONKEYS. THE RESEARCHERS ALSO FOUND SIGNIFICANTLY REDUCED LEVELS OF SHIV DNA IN THE BLOOD TWO WEEKS AFTER THE ANTIBODIES WERE ADMINISTERED; IN THE LYMPH NODES, SHIV DNA DROPPED MARKEDLY AFTER 10 WEEKS. THE AUTHORS CONCLUDED THAT PASSIVE IMMUNIZATION USING THESE ANTIBODIES COULD, UNDER THE RIGHT CONDITIONS, ERADICATE THE HIV RESERVOIR. USING GROUNDBREAKING CAR-T CANCER THERAPY TO CURE HIV HIV RESEARCH PLAYED A CRITICAL ROLE IN THE DEVELOPMENT OF KYMRIAH, THE FDAS FIRST APPROVED GENE THERAPY TREATMENT FOR CANCER. THE CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPY INVOLVES MODIFYING A PATIENTS OWN T CELLS TO SEEK AND DESTROY CANCER CELLS. IN THE SEPTEMBER 2017 ISSUE OF THE JOURNAL TRANSLATIONAL RESEARCH, AMFAR-FUNDED SCIENTIST DR. SCOTT KITCHEN AND COLLEAGUES FROM THE UNIVERSITY OF CALIFORNIA, LOS ANGELES, NOTED THAT THE FIRST CAR T CELLS USED IN CLINICAL TRIALS WERE DESIGNED TO TREAT HIV. HOWEVER, UNLIKE CANCER, HIV CAN ATTACK THE VERY CAR T CELLS ADMINISTERED TO FIGHT THE INFECTION. KITCHEN AND ASSOCIATES DISCUSSED SEVERAL NOVEL APPROACHES TO ENHANCE THE ACTIVITY OF ANTI-HIV CAR T CELLS AND TO PROTECT THEM AGAINST INFECTION, INCLUDING REMOVING, THROUGH GENETIC ENGINEERING, THE PRIMARY HIV CO-RECEPTOR CCR5, AND USING A COMBINATION APPROACH TO KILL INFECTED CELLS AND ELIMINATE LATENT HIV RESERVOIRS. HIV CURE SUMMIT IN DECEMBER 2016, AMFAR HELD ITS THIRD ANNUAL HIV CURE SUMMIT AT UCSF, WHERE THE AMFAR INSTITUTE FOR HIV CURE RESEARCH IS BASED. LEADING AMFAR-FUNDED CURE RESEARCHERS DETAILED THEIR PROGRESS AND DISCUSSED THE SCIENTIFIC CHALLENGES THAT CONTINUE TO STAND IN THE WAY OF A CURE. DR. PETER HUNT REPORTED ON THE EFFORTS OF HIS TEAM TO CHART, OR PINPOINT, THE PRECISE LOCATIONS OF THE RESERVOIR USING A "FACIAL RECOGNITION SOFTWARE" KNOWN AS CYTOF. DR. WARNER GREENE DISCUSSED THE "SHOCK-AND- KILL" APPROACH TO ERADICATING HIV: FINDING AGENTS THAT CAN EFFECTIVELY "SHOCK" LATENT VIRUS OUT OF ITS HIDING PLACE SO THAT IT CAB BE "KILLED" BY THE IMMUNE SYSTEM OR INTERVENTIONS SUCH AS A THERAPEUTIC VACCINE OR BROADLY NEUTRALIZING ANTIBODIES. DR. SATISH PILLAI TALKED ABOUT THE MULTIPLE CHALLENGES INHERENT IN DETERMINING EXACTLY HOW MUCH VIRUS IS IN THE PERSISTENT HIV RESERVOIR. HE AND HIS COLLEAGUES ARE DEVELOPING HIGHLY SENSITIVE TOOLS THAT ARE MORE EFFECTIVE AT IDENTIFYING TINY AMOUNTS OF RESIDUAL VIRUS. AND DR. STEVEN DEEKS PROVIDED AN UPDATE ON HIS WORK TO TAKE THE EXPERIMENTAL INTERVENTIONS DEVELOPED BY INSTITUTE RESEARCHERS AND TEST THEM IN CLINICAL TRIALS. HIV RESEARCH SUMMIT IN BRAZIL IN A COMMUNITY EDUCATION INITIATIVE, AMFAR HOSTED AN HIV RESEARCH SUMMIT AT THE UNIVERSITY OF SO PAULO, BRAZIL, IN MARCH 2017, BRINGING TOGETHER 250 COMMUNITY MEMBERS, MEDICAL STUDENTS, HEALTHCARE PROFESSIONALS, AND REPRESENTATIVES FROM 10 SO PAULO-BASED NONGOVERNMENTAL ORGANIZATIONS. THE SUMMIT WAS HELD IN CONJUNCTION WITH THE ADVANCED COURSE ON HIV PATHOGENESIS AT THE UNIVERSITYS SCHOOL OF MEDICINE. SPEAKERS INCLUDED AMFAR VICE PRESIDENT AND DIRECTOR OF RESEARCH DR. ROWENA JOHNSTON; DR. MARIO STEVENSON, A PROFESSOR OF MEDICINE AT THE UNIVERSITY OF MIAMIS MILLER SCHOOL OF MEDICINE; AND DR. ESPER KALLAS, AN INFECTIOUS DISEASE SPECIALIST AND A PROFESSOR AT THE UNIVERSITY OF SO PAULO SCHOOL OF MEDICINE. THINK TANKS CONSISTENT WITH AMFARS COMMITMENT TO INVESTIGATE EVERY AVENUE THAT MAY LEAD TO A CURE, THE FOUNDATION REGULARLY HOSTS THINK TANKS THAT BRING TOGETHER LEADING INVESTIGATORS IN VARIOUS FIELDS. IN OCTOBER 2016, AMFAR HOSTED A THINK TANK IN LISBON, PORTUGAL, TITLED "PROGRESS REPORT: RESEARCH TOWARD A CURE FOR AIDS IN THE CONTEXT OF ICISTEM." ICISTEM IS A CONSORTIUM OF 17 EUROPEAN RESEARCHES THAT AIMS TO REPLICATE THE CASE OF "THE BERLIN PATIENT." IT WAS CREATED AND IS FUNDED BY AMFAR THROUGH ITS COUNTDOWN TO A CURE FOR AIDS INITIATIVE. AMFAR HOSTED ANOTHER THINK TANK IN APRIL 2017 IN PALO ALTO, CA, ON STRATEGIES TO IDENTIFY LATENTLY INFECTED CELLS. THE RESEARCHERS DISCUSSED FINDING A BIOMARKER FOR THESE CELLS AS AN ALTERNATIVE APPROACH TO "SHOCK AND KILL." ONE OF THE BIGGEST CHALLENGES WITH THE "SHOCK-AND-KILL" STRATEGY IS THAT CURRENT DRUG REGIMENS DO NOT REAWAKEN ALL OF THE INFECTED CELLS. PROGRAM SERVICE ACCOMPLISHMENTS (2) LINE 4B: TREAT ASIA: AMFARS TREAT ASIA (THERAPEUTICS RESEARCH, EDUCATION, AND AIDS TRAINING IN ASIA) PROGRAM IS A NETWORK OF HOSPITALS, CLINICS, AND RESEARCH INSTITUTIONS WORKING WITH CIVIL SOCIETY TO ENSURE THE SAFE AND EFFECTIVE DELIVERY OF TREATMENTS FOR HIV AND ITS CO-INFECTIONS TO ADULTS AND CHILDREN ACROSS THE ASIA-PACIFIC THROUGH RESEARCH, EDUCATION, AND ADVOCACY OF EVIDENCE-BASED HIV-RELATED POLICIES. THE TREAT ASIA NETWORK ENCOMPASSES 21 ADULT AND 20 PEDIATRIC SITES THROUGHOUT THE REGION, WHICH COLLABORATE ON A VARIETY OF PROJECTS. TREAT ASIA SCIENTISTS PRODUCED A RECORD 35 PUBLICATIONS IN PEER-REVIEWED MEDICAL JOURNALS IN 2017. INTERNATIONAL AIDS DATABASE TREAT ASIA MANAGES THE ASIA-PACIFIC SECTION OF THE INTERNATIONAL EPIDEMIOLOGIC DATABASES TO EVALUATE AIDS (IEDEA), A GLOBAL COLLABORATION ESTABLISHED BY THE U.S. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. IN FY2017, THE IEDEA CONSORTIUM FUNDED THE SECOND YEAR OF STAY (STUDY OF TRANSITIONING ASIAN YOUTH), WHICH AIMS TO DOCUMENT THE EXPERIENCE OF HIV-INFECTED YOUNG ADULTS WHO ARE TRANSITIONING FROM PEDIATRIC TO ADULT CARE. TREAT ASIA HIV OBSERVATIONAL DATABASE (TAHOD) TREAT ASIA PIONEERED THE REGIONS FIRST ADULT OBSERVATIONAL DATABASE FOR HIV/AIDS, WHICH NOW INCLUDES ANONYMOUS DATA FROM APPROXIMATELY 9,200 PATIENTS AT 21 CLINICAL SITES IN 12 COUNTRIES. THE INFORMATION GATHERED IN THE DATABASE INFORMS THE DEVELOPMENT OF MORE EFFECTIVE RESEARCH AND TREATMENT PROGRAMS AND HELPS DEFINE TREATMENT STANDARDS SPECIFIC TO HIV/AIDS IN ASIA. TAHOD LOW-INTENSITY TRANSFER (TAHOD-LITE) LAUNCHED IN 2014, TAHOD LOW-INTENSITY TRANSFER (TAHOD-LITE) CONTAINS DATA FROM OVER 37,000 HIV-POSITIVE PATIENTS ACROSS 10 TREAT ASIA NETWORK SITES. AS AN EXTENSION OF TAHOD, TAHOD-LITE AIMS TO INCREASE THE SCOPE OF ADULT DATA COLLECTION BY GATHERING A SUBSET OF CORE VARIABLES FROM THE ENTIRE COHORT OF HIV-INFECTED PATIENTS WHO HAVE SOUGHT CARE AT SELECTED TAHOD SITES. TREAT ASIA PEDIATRIC HIV OBSERVATIONAL DATABASE (TAPHOD) THE TREAT ASIA PEDIATRIC HIV OBSERVATIONAL DATABASE (TAPHOD) IS A REGIONAL PEDIATRIC HIV STUDY SET UP BY TREAT ASIA IN 2006. IT WAS MODELED AFTER THE ADULT DATABASE AND INCLUDES DATA FROM MORE THAN 6,400 CHILDREN AND ADOLESCENTS AT 19 CLINICAL SITES IN CAMBODIA, INDIA, INDONESIA, MALAYSIA, THAILAND, AND VIETNAM. ADDRESSING ADOLESCENT MENTAL HEALTH IN JANUARY 2017, TREAT ASIA ORGANIZED A THINK TANK IN BANGKOK ON ADOLESCENT MENTAL HEALTH, BRINGING TOGETHER REGIONAL INVESTIGATORS AND YOUTH ADVOCATES FROM CAMBODIA, INDONESIA, MALAYSIA, THAILAND, AND VIETNAM TO DISCUSS HOW TO ADDRESS RESEARCH AND CLINICAL TRAINING GAPS. AS A RESULT OF THE DISCUSSION, TREAT ASIA IS EVALUATING THE PREVALENCE OF MENTAL HEALTH DISORDERS AMONG HIV-INFECTED ADOLESCENTS IN THE REGION AND DEVELOPING TRAININGS FOR PEDIATRIC HIV PROVIDERS ON MENTAL HEALTH MANAGEMENT. |
| PROGRAM SERVICE ACCOMPLISHMENTS (2) CONT. | IN JUNE 2017, TREAT ASIA HOSTED A TRAINING IN BANGKOK TO HELP CLINICIANS BETTER DIAGNOSE AND MANAGE MENTAL HEALTH DISORDERS IN ADOLESCENTS LIVING WITH HIV. THE WORKSHOP BROUGHT TOGETHER MORE THAN 30 CLINICAL AND MENTAL HEALTH PROFESSIONALS WHO WORK WITH HIV-POSITIVE YOUTH IN THAILAND, CAMBODIA, INDONESIA, AND MALAYSIA. THE TRAINING REVIEWED THE EPIDEMIOLOGY OF ADOLESCENT MENTAL HEALTH ISSUES, MENTAL HEALTH NEEDS AMONG YOUTH LIVING WITH HIV, PSYCHOPHARMACOLOGY, AND SUICIDE RISK ASSESSMENT TOOLS. EMPOWERING YOUTH ADVOCATES IN JUNE 2017, THE FIRST CLASS OF TREAT ASIA'S YOUTH ACATA-ASIA COMMUNITY FOR AIDS TREATMENT AND ADVOCACY-HELD ITS FINAL WORKSHOP IN BANGKOK, WHERE EIGHT YOUNG PEOPLE LIVING WITH HIV FROM CAMBODIA, INDONESIA, AND THAILAND GRADUATED FROM THE TWO-YEAR LEADERSHIP TRAINING PROGRAM. LAUNCHED IN 2015 WITH SUPPORT FROM VIIV HEALTHCARES POSITIVE ACTION FOR ADOLESCENTS PROGRAM, YOUTH ACATA AIMS TO EDUCATE PARTICIPANTS ABOUT HIV AND ANTIRETROVIRAL THERAPY AND CONNECT THEM TO OTHER HIV-POSITIVE YOUTH IN THE REGION.THE REGION. HELPING ADOLESCENTS TRANSITION TO ADULT CARE IN FY2017, TREAT ASIA CONTINUED WORKING TO HELP ADOLESCENTS LIVING WITH HIV TRANSITION TO ADULT CARE. WITH FUNDING FROM AIDS LIFE AUSTRIA, THE PROGRAM PROVIDED A GRANT TO THE CHILDREN AND YOUTH PROGRAM OF SEARCH (SOUTH EAST ASIA RESEARCH COLLABORATION ON HIV) AT THE THAI RED CROSS AIDS RESEARCH CENTRE IN BANGKOK TO IMPLEMENT A TRANSITION MODEL THAT FOCUSES ON ISSUES SUCH AS MOVING TO ADULT CARE, COPING WITH NEGATIVE EMOTIONS, TREATMENT, AND STIGMA. ADVOCATING FOR CO-INFECTION TREATMENT ACCESS IN JUNE 2017, TREAT ASIA HELD ITS ANNUAL REGIONAL ADVOCACY MEETING ON HEPATITIS C, HIV, AND TUBERCULOSIS TREATMENT IN BANGKOK, WITH CIVIL SOCIETY ORGANIZATIONS, CLINICAL CARE PROFESSIONALS, AND INTELLECTUAL PROPERTY EXPERTS. DURING THE YEAR, TREAT ASIA ALSO ATTENDED AND PRESENTED AT SEVERAL CONFERENCES ON HEPATITIS C TREATMENT ACCESS AND PARTNERED WITH CIVIL SOCIETY GROUPS AND FUNDERS ON ADVOCACY EFFORTS. INTRODUCING PREP TO THE PHILIPPINES IN JULY 2017, ENROLLMENT BEGAN FOR A TWO-YEAR PILOT PROJECT THAT INTRODUCES ANTIRETROVIRAL PRE-EXPOSURE PROPHYLAXIS (PREP) TO THE PHILIPPINES IN AN EFFORT TO CURB THE RAPID SPREAD OF HIV INFECTION AMONG MEN WHO HAVE SEX WITH MEN (MSM) AND TRANSGENDER INDIVIDUALS. THE PROJECT, KNOWN AS PREPPY (PREP PILIPINAS), WILL EVALUATE COMMUNITY-BASED, PEER-DRIVEN DELIVERY OF PREP AT TWO CLINICS IN MANILA. AMFAR IS AMONG SEVERAL ORGANIZATIONS INVOLVED IN PROJECT PREPPY, A MULTIAGENCY COLLABORATION WITH EXPERTS FROM GOVERNMENT, ACADEMIA, AND MULTILATERAL AND NONGOVERNMENTAL ORGANIZATIONS. PUBLICATIONS IN NOVEMBER 2016, TREAT ASIA, IN CONJUNCTION WITH AMFARS PUBLIC POLICY OFFICE, PRODUCED A REPORT TITLED CERVICAL CANCER, HUMAN PAPILLOMAVIRUS (HPV), AND HPV VACCINES IN SOUTHEAST ASIA: KEY CONSIDERATIONS FOR EXPANDING VACCINE COVERAGE AND IMPROVING POPULATION HEALTH. THE REPORT DOCUMENTS THE SLOW UPTAKE OF HPV VACCINATION IN THE REGION AND GIVES RECOMMENDATIONS FOR INCREASING USE OF THE VACCINE. IN MARCH 2017, TREAT ASIA PRODUCED THE FACT SHEET PREP ACCEPTABILITY AMONG FEMALE SEX WORKERS IN THAILAND: KEY RESEARCH FINDINGS BASED ON A STUDY JOINTLY CONDUCTED BY THE INSTITUTE FOR POPULATION AND SOCIAL RESEARCH AT MAHIDOL UNIVERSITY IN BANGKOK, JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH IN BALTIMORE, AND THE COMMUNITY-BASED ORGANIZATION SERVICE WORKERS IN GROUP (SWING) FOUNDATION. HIV PREVALENCE AMONG THAI FEMALE SEX WORKERS IS SIGNIFICANTLY HIGHER THAN IN THE GENERAL POPULATION, AND ANTIRETROVIRAL PRE-EXPOSURE PROPHYLAXIS (PREP) MAY HELP REDUCE INFECTION RATES. IN SEPTEMBER 2017, TREAT ASIA CREATED THE FIRST IN A SERIES OF INFOGRAPHICS TITLED WHY HAS ASIA FALLEN BEHIND ON HIV/AIDS? TO ILLUSTRATE THE STAGNATION IN HIV PROGRAM COVERAGE IN THE ASIA-PACIFIC. THE STAGNATION IS A REMINDER TO GOVERNMENTS, CIVIL SOCIETY, AND DONORS THAT MUCH MORE NEEDS TO BE DONE TO BRING HIV/AIDS UNDER CONTROL IN THE REGION. IN ADDITION, TREAT ASIA CONTINUED TO PUBLISH LAY-LANGUAGE ARTICLES ON HIV/AIDS RESEARCH, POLICY, AND COMMUNITY ISSUES FACING THE ASIA-PACIFIC AS A WHOLE. THE ARTICLES AND EDUCATIONAL PIECES APPEAR IN THE TREAT ASIA REPORT, A BIMONTHLY E-NEWSLETTER, AND ON TREAT ASIAS WEBSITE, WWW.TREATASIA.ORG. 16TH ANNUAL NETWORK MEETING THE 2016 TREAT ASIA ANNUAL NETWORK MEETING WAS HELD IN OCTOBER 2016 IN HANOI, VIETNAM, WHERE MORE THAN 120 ADULT AND PEDIATRIC INVESTIGATORS, DONORS, AND PROGRAM PARTNERS GATHERED TO REVIEW PROGRESS ON THE NETWORKS RESEARCH AGENDA, HEAR ABOUT REGIONAL HIV-RELATED POLICY PRIORITIES, AND PLAN FOR FUTURE INITIATIVES. THE MEETING INCLUDED SPECIAL PRESENTATIONS ON A WIDE RANGE OF PROJECTS INCLUDING: - A PILOT PROGRAM INTRODUCING PRE-EXPOSURE PROPHYLAXIS (PREP) TO MEN WHO HAVE SEX WITH MEN AND TRANSGENDER INDIVIDUALS, A STUDY SUPPORTED BY AMFAR AND PRESENTED BY DR. ROSSANA DITANGCO OF THE RESEARCH INSTITUTE FOR TROPICAL MEDICINE IN THE PHILIPPINES; - RESEARCH AND POLICY INITIATIVES TO FIGHT HIV, HEPATITIS C, AND SEXUALLY TRANSMITTED INFECTIONS IN THE ASIA-PACIFIC, PRESENTED BY DR. YING-RU LO OF THE WORLD HEALTH ORGANIZATIONS WESTERN PACIFIC REGIONAL OFFICE; AND - TREAT ASIA/INTERNATIONAL EPIDEMIOLOGIC DATABASES TO EVALUATE AIDS (IEDEA) ASIA-PACIFIC RESEARCH, PRESENTED BY DR. CAROLYN WILLIAMS OF THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. OTHER CONFERENCES TREAT ASIA STAFF AND NETWORK INVESTIGATORS ATTENDED AND PRESENTED AT SEVERAL REGIONAL AND INTERNATIONAL CONFERENCES ON HIV-RELATED ISSUES. EXAMPLES INCLUDE: IAS 2017 TREAT ASIA HAD A STRONG PRESENCE AT THE 9TH INTERNATIONAL AIDS SOCIETY CONFERENCE ON HIV SCIENCE IN PARIS IN JULY. DR. NITTAYA PHANUPHAK OF THE THAI RED CROSS AIDS RESEARCH CENTRE IN BANGKOK WAS ON THE EPIDEMIOLOGY AND PREVENTION RESEARCH PLANNING COMMITTEE, WHILE DR. ADEEBA KAMARULZAMAN OF THE UNIVERSITY OF MALAYA SERVED ON THE IMPLEMENTATION RESEARCH PLANNING COMMITTEE. IN ADDITION, DRS. KAMARULZAMAN, ANCHALEE AVIHINGSANON OF THE THAI RED CROSS AIDS RESEARCH CENTRE, AND ANETTE SOHN, DIRECTOR OF TREAT ASIA, CO-CHAIRED VARIOUS SESSIONS AND FACILITATED WORKSHOPS. SEVEN TREAT ASIA GRANTEES MADE PRESENTATIONS. APACC TREAT ASIA WAS ALSO WELL REPRESENTED AT THE SECOND ASIA PACIFIC AIDS & CO-INFECTIONS CONFERENCE (APACC), HELD JUNE 1-3, 2017, IN HONG KONG. APACC IS A REGIONAL-LEVEL HIV RESEARCH CONFERENCE THAT PROVIDES OPPORTUNITIES FOR LOCAL CLINICIANS, STUDENTS, AND RESEARCHERS TO SUBMIT ABSTRACTS FOR PRESENTATION. THE CO-CHAIRS INCLUDED TREAT ASIA DIRECTOR DR. ANNETTE SOHN AND CURRENT AND FORMER TREAT ASIA NETWORK INVESTIGATORS DRS. PATRICK CHUNG-KI LI, FORMERLY OF QUEEN ELIZABETH HOSPITAL IN HONG KONG, AND ADEEBA KAMARULZAMAN. PROGRAM SERVICE ACCOMPLISHMENTS (3) LINE 4C: PUBLIC INFORMATION: AMFAR SEEKS TO TRANSLATE AND DISSEMINATE INFORMATION ON IMPORTANT HIV-RELATED RESEARCH, TREATMENT, PREVENTION, AND POLICY ISSUES FOR DIVERSE AUDIENCES AND TO INCREASE AWARENESS AND KNOWLEDGE OF THE PANDEMIC. AMFAR PUBLISHES A WIDE RANGE OF EDUCATIONAL MATERIALS, MAINTAINS AN INFORMATIVE WEBSITE, AND ENGAGES RESPECTED PUBLIC FIGURES, HIV/AIDS SCIENTISTS, AND POLICYMAKERS IN COMMUNICATING THE NEED FOR CONTINUED RESEARCH TO DEVELOP NEW METHODS OF PREVENTION, TREATMENT, AND, ULTIMATELY, A CURE FOR HIV. EDUCATIONAL MATERIALS AMFAR PRODUCES A RANGE OF PERIODICALS IN BOTH PRINT AND ELECTRONIC FORMATS, INCLUDING ITS NEWSLETTER INNOVATIONS, PUBLISHED TWICE A YEAR AND DISTRIBUTED TO MORE THAN 40,000 PEOPLE; THE TREAT ASIA REPORT, AN EMAIL NEWSLETTER DISTRIBUTED SIX TIMES A YEAR TO MORE THAN 4,000 READERS IN THE INTERNATIONAL HEALTH COMMUNITY; AND A MONTHLY E-MAIL NEWSLETTER DISTRIBUTED TO NEARLY 70,000 PEOPLE. THE FOUNDATIONS WEBSITES - WWW.AMFAR.ORG AND WWW.CURECOUNTDOWN.ORG - FEATURE NEWS, INTERVIEWS, AND ORIGINAL ARTICLES COVERING HIV RESEARCH, POLICY, THE GLOBAL EPIDEMIC, AND AMFAR PROGRAMS AND ACTIVITIES. THE WEBSITES ATTRACT A COMBINED AVERAGE OF 45,000 VISITORS PER MONTH. AMFAR ALSO CREATES AND DISTRIBUTES REPORTS, PRESS RELEASES, AND UPDATES ON MAJOR HIV/AIDS ISSUES AND CONDUCTS PUBLIC SERVICE ADVERTISING CAMPAIGNS THAT HAVE BEEN INSTRUMENTAL IN EDUCATING POLICYMAKERS, HEALTHCARE PROFESSIONALS, PEOPLE LIVING WITH HIV/AIDS, AND THE PUBLIC. EPIC VOICES IN JUNE 2017, AMFAR LAUNCHED EPIC VOICES, AN ONLINE VIDEO SERIES THAT AIMS TO REENERGIZE THE RESPONSE TO HIV AMONG MILLENNIAL AND LGBTQ COMMUNITIES. THE GOALS OF THE CAMPAIGN ARE TO: RENEW AWARENESS OF THE PERSISTENT THREAT OF HIV, UNDERSCORE THE URGENT NEED TO SUPPORT HIV RESEARCH, AND SUPPORT AMFARS LEADERSHIP IN THE SEARCH FOR A CURE. AMFAR SPOKE TO HIV ACTIVISTS ACROSS THE COUNTRY AND ASKED THEM TO SHARE THEIR UNIQUE JOURNEYS, THEIR INSIGHTS ON LIVING WITH HIV, AND THE BOLD STEPS THEY HAVE TAKEN IN THE FIGHT AGAINST THE EPIDEMIC. |
| PROGRAM SERVICE ACCOMPLISHMENTS (3) CONT. | SOCIAL MEDIA AMFAR HAS VIGOROUSLY EXPANDED ITS PRESENCE IN THE SOCIAL MEDIA ARENA, REACHING LARGE NUMBERS OF PEOPLE, INCLUDING A YOUNGER DEMOGRAPHIC THAT IS OFTEN LESS EDUCATED ABOUT HIV AND THE AIDS EPIDEMIC. THE FOUNDATION REGULARLY ADDS CONTENT TO ITS FACEBOOK PAGE, LIVE TWEETS FROM EVENTS, AND POSTS IMAGES ON INSTAGRAM FROM FUNDRAISING AND PROGRAM EVENTS. AMFAR HAS 74,000 LIKES ON FACEBOOK, 43,000 TWITTER FOLLOWERS, AND MORE THAN 130,000 INSTAGRAM FOLLOWERS. MEDIA OUTREACH IN FY2017, AMFAR CONTINUED TO WORK CLOSELY WITH THE MEDIA TO RAISE THE PROFILE OF HIV/AIDS, BOTH DOMESTICALLY AND INTERNATIONALLY, AND TO HELP ENSURE THE ACCURACY OF HIV - RELATED PRESS COVERAGE. ARTICLES AND REPORTS INVOLVING AMFAR - MANY OF WHICH INCLUDED INTERVIEWS WITH STAFF - WERE CARRIED IN NUMEROUS MEDIA OUTLETS, INCLUDING THE NEW YORK TIMES, THE WASHINGTON POST, THE CHICAGO TRIBUNE, THE HILL, POLITICO, NBC NEWS, CBS NEWS, CNBC, U.S. NEWS & WORLD REPORT, REUTERS, EBONY, AND HUFFPOST. CELEBRITY SUPPORT AMFARS PUBLIC AWARENESS EFFORTS ARE GREATLY ENHANCED BY THE COMMITTED SUPPORT OF PUBLIC FIGURES WHO LEND THEIR VOICES AND DONATE THEIR TIME, TALENTS, AND RESOURCES TO HELP SUSTAIN THE FOUNDATIONS MISSION. SUPPORT OF AMFAR BY PROMINENT PUBLIC FIGURES BEGAN WITH THE LATE DAME ELIZABETH TAYLOR, AMFARS FOUNDING INTERNATIONAL CHAIRMAN, AND OTHERS HAVE FOLLOWED IN HER FOOTSTEPS. AMFAR IS PROFOUNDLY GRATEFUL FOR THE CONTINUING STEADFAST SUPPORT OF GLOBAL CAMPAIGN CHAIR SHARON STONE. OTHER CELEBRITY SUPPORTERS INCLUDED AMFAR AMBASSADORS MILLA JOVOVICH, MICHELLE YEOH, CHEYENNE JACKSON, AND LIZA MINNELLI, CHARLIZE THERON, ADRIEN BRODY, JESSICA CHASTAIN, MATT BOMER, DITA VON TEESE, GWYNETH PALTROW, DIANA ROSS, CHIARA FERRAGNI, DIANE KRUGER, IMAN, KATIE HOLMES, UMA THURMAN, KATE MOSS, ZAC POSEN, ZOE SALDANA, TOBEY MAGUIRE, DAME HELEN MIRREN, LEA MICHELE, MICHELLE RODRIGUEZ, WILL SMITH, NICOLE KIDMAN, NAOMI CAMPBELL, HEIDI KLUM, JON HAMM, EVA LONGORIA, LEONARDO DICAPRIO, ROBERT DE NIRO, NICKI MINAJ, ANDREA BOCELLI, DEAN AND DAN CATEN, CHRIS TUCKER, JENNIFER GARNER, SCARLETT JOHANSSON, DONATELLA VERSACE, VICTORIA JUSTICE, AND CARINE ROITFELD.AND CARINE ROITFELD. PROGRAM SERVICE ACCOMPLISHMENTS (4) LINE 4D: THE GMT INITIATIVE: IMPLEMENTATION SCIENCE AWARDS IN FY2017, AMFARS GRANT MAKING THROUGH THE GMT INITIATIVE SUPPORTED A TRIO OF LARGE IMPLEMENTATION SCIENCE PROJECTS AIMED AT IDENTIFYING BARRIERS TO HIV TESTING, TREATMENT, AND CARE AND STUDYING THE IMPACT OF INNOVATIVE HIV SERVICE DELIVERY MODELS FOR GAY MEN, OTHER MEN WHO HAVE SEX WITH MEN, AND TRANSGENDER INDIVIDUALS (COLLECTIVELY, GMT) IN LOW- AND MIDDLE-INCOME COUNTRIES. AMFAR HAS AWARDED $2.6 MILLION OVER THREE YEARS TO SUPPORT THE STUDIES. DR. CHRIS BEYRER OF JOHNS HOPKINS UNIVERSITY IN BALTIMORE IS LEADING A TEAM OF RESEARCHERS AND COMMUNITY-BASED SERVICES (IN COLLABORATION WITH THE INTERNATIONAL HIV/AIDS ALLIANCE MYANMAR) IN EVALUATING THE EFFECTIVENESS OF PROMISING INTERVENTIONS FOR GMT IN MYANMAR, WHERE INCREASED HIV TESTING AND TREATMENT OPPORTUNITIES ARE BECOMING AVAILABLE. THE RESEARCHERS ARE ASSESSING THE EFFECTIVENESS OF HIV SELF-TESTING DONE IN THE PRIVACY OF ONES HOME, POINT-OF-CARE CD4 TESTING, AND THE USE OF "PEER NAVIGATORS" FAMILIAR WITH THE LOCAL HEALTH SYSTEM TO HELP THOSE NEWLY DIAGNOSED GAIN ACCESS TO HIV TREATMENT AND CARE. IN LIMA, PERU, DR. JAVIER LAMA OF ASOCIACIN CIVIL IMPACTA SALUD Y EDUCACIN AND HIS TEAM ARE AIMING TO IMPROVE THE CONTINUUM OF CARE AMONG TRANSGENDER WOMEN BY USING AN INNOVATIVE MODEL THAT INTEGRATES HIV PREVENTION AND TREATMENT SERVICES WITH TRANSGENDER-AFFIRMING MEDICAL CARE. WORKING IN COLLABORATION WITH THE BOSTON-BASED FENWAY INSTITUTE AND TWO COMMUNITY GMT ORGANIZATIONS, LAMA AND HIS TEAM ARE INTEGRATING ROUTINE CROSS-SEX HORMONE THERAPY INTO HIV AND SEXUALLY TRANSMITTED INFECTION PREVENTION, TESTING, AND TREATMENT SERVICES AND IMPLEMENTING HEALTH SERVICES AND PEER CASE MANAGEMENT FOR 200 TRANSGENDER WOMEN. AND IN BANGKOK, DR. NITTAYA PHANUPHAK AND HER TEAM AT THE THAI RED CROSS AIDS RESEARCH CENTRE ARE WORKING TO SHOW HOW INNOVATIVE TECHNOLOGIES SUCH AS GMT-TARGETED WEBSITES USING ONLINE COUNSELING AND SUPPORT CAN BE UTILIZED TO INCREASE RATES OF HIV TESTING AND REFERRALS TO PREVENTION AND TREATMENT PROGRAMS. WORKING IN COLLABORATION WITH ADAMS LOVE, A WEB-BASED HEALTH PLATFORM FOR GMT INDIVIDUALS, AND TWO COMMUNITY-BASED ORGANIZATIONS (SERVICE WORKERS IN GROUP/SWING AND THE RAINBOW SKY ASSOCIATION OF THAILAND), THE TEAM IS COMPARING THE EFFECTIVENESS OF ONLINE SERVICES AND SUPPORT INTERVENTIONS WITH TRADITIONAL CLINIC-BASED HIV SERVICES, AND A HYBRID MODEL THAT COMBINES ELEMENTS OF BOTH STRATEGIES. PUBLICATIONS IN DECEMBER 2016, AMFAR AND THE UNIVERSITY OF PITTSBURGH PRODUCED A SUPPLEMENT TO THE JOURNAL AIDS AND BEHAVIOR DEVOTED TO THE HIV SCHOLARS PROGRAM AT THE UNIVERSITYS CENTER FOR LGBT HEALTH RESEARCH. THE AMFAR-FUNDED PROGRAM HAS SUPPORTED RESEARCH TRAINING FOR 16 YOUNG INVESTIGATORS FROM LOW- AND MIDDLE-INCOME COUNTRIES, AS WELL AS THEIR INDIVIDUAL RESEARCH PROJECTS FOCUSED ON HIV AND AIDS AMONG GMT. SCHOLARS HAVE COME FROM A WIDE RANGE OF COUNTRIES, INCLUDING PAKISTAN, CHINA, SOUTH AFRICA, LEBANON, AND BELIZE, AMONG OTHERS. |
| PROGRAM SERVICE ACCOMPLISHMENTS (5) | LINE 4D: PUBLIC POLICY: INFORMED BY THOROUGH RESEARCH AND ANALYSIS, AMFAR IS A HIGHLY RESPECTED ADVOCATE OF RATIONAL AND COMPASSIONATE HIV/AIDS-RELATED PUBLIC POLICY. THE FOUNDATION IS ENGAGED IN EFFORTS TO SECURE NECESSARY INCREASES IN FUNDING FOR HIV/AIDS RESEARCH; IMPLEMENT THE U.S. NATIONAL HIV/AIDS STRATEGY; EXPAND ACCESS TO CARE AND TREATMENT; AND PROTECT THE CIVIL RIGHTS OF ALL PEOPLE AFFECTED BY HIV/AIDS. ENDING THE DOMESTIC HIV EPIDEMIC IN OCTOBER 2016, AMFAR PUBLISHED A REPORT THAT RECOMMENDS SEVERAL MEASURES HEALTH PLANS AND HEALTHCARE PURCHASERS, INCLUDING MEDICARE AND MEDICAID PROGRAMS AND PRIVATE INSURERS, CAN TAKE TO HELP END THE DOMESTIC HIV EPIDEMIC. CURBING THE HIV EPIDEMIC BY SUPPORTING EFFECTIVE ENGAGEMENT IN HIV CARE: RECOMMENDATIONS FOR HEALTH PLANS AND HEALTH CARE PURCHASERS OUTLINES ACTIONABLE STEPS TO IMPROVE HEALTH OUTCOMES, REDUCE UNNECESSARY SPENDING, AND CONTRIBUTE TO THE DEVELOPMENT OF MORE INTEGRATED SYSTEMS OF CARE FOR PEOPLE LIVING WITH HIV. IN NOVEMBER 2016, AMFAR, IN CONJUNCTION WITH TREATMENT ACTION GROUP, PUBLISHED A REPORT IN THE JOURNAL OF THE INTERNATIONAL AIDS SOCIETY PROPOSING A CONCEPTUAL FRAMEWORK FOR AN INTEGRATED PRIMARY AND SECONDARY HIV PREVENTION CONTINUUM FOR THE UNITED STATES. THE MODEL IS BASED ON THE WIDELY USED HIV CARE CONTINUUM, WHICH TRACKS THE PERCENTAGE OF THE POPULATION LIVING WITH HIV WHO ARE DIAGNOSED, TREATED, AND ULTIMATELY VIRALLY SUPPRESSED, AND FOCUSES ON THE REDUCTION OF HIV ACQUISITION THROUGH ENGAGEMENT IN HIV PREVENTION SERVICES. CAPITOL HILL BRIEFING IN JUNE 2017, GOVERNMENT OFFICIALS, SCIENTISTS, AND PUBLIC HEALTH LEADERS CONVENED AT THE AMFAR CAPITOL HILL CONFERENCE, "MAKING AIDS HISTORY: A ROADMAP FOR ENDING THE EPIDEMIC." THE CONFERENCE HIGHLIGHTED THE LATEST ADVANCES IN HIV PREVENTION, TREATMENT, AND RESEARCH AND ADDRESSED THE CHALLENGES THAT REMAIN IN ERADICATING THE VIRUS. SPEAKERS AND PANELISTS DISCUSSED THE NATIONAL SECURITY IMPLICATIONS OF EPIDEMICS, THE ECONOMIC AND HEALTH IMPACT OF AGING WITH HIV, AND THE OPIOID CRISIS AND ITS RELATIONSHIP TO HIV AND OTHER INFECTIOUS DISEASES. HIV AND THE OPIOID EPIDEMIC IN JUNE 2017, AMFAR LAUNCHED A COMPREHENSIVE ONLINE DATABASE TO HELP COMMUNITIES, POLICYMAKERS, AND ADVOCATES EFFECTIVELY RESPOND TO THE OPIOID EPIDEMIC. THE OPIOID & HEALTH INDICATORS DATABASE PROVIDES LOCAL AND NATIONAL STATISTICS ON HIV AND HEPATITIS C INFECTIONS, OPIOID USE, OVERDOSE DEATH RATES, AND THE AVAILABILITY OF SERVICES SUCH AS DRUG TREATMENT AND SYRINGE SERVICES PROGRAMS. AMFAR ALSO PUBLISHED AN ISSUE BRIEF OUTLINING THE CASE FOR SUPERVISED CONSUMPTION SERVICES (SCS), WHICH PROVIDE A HYGIENIC SPACE FOR PEOPLE TO USE ILLICIT DRUGS UNDER THE SUPERVISION OF TRAINED STAFF. THE FACILITIES ARE DESIGNED TO REDUCE THE RISK OF HIV/HEPATITIS C TRANSMISSION, PREVENT OVERDOSE FATALITIES, AND PROVIDE A BRIDGE TO TREATMENT AND OTHER SOCIAL SERVICES. SCS HAVE BEEN SHOWN TO LOWER RATES OF SYRINGE SHARING, REDUCE PUBLIC INJECTING, AND PROMOTE SAFER AND MORE HYGIENIC DRUG USE. GLOBAL HEALTH IN JANUARY 2017, AMFAR PUBLISHED A REPORT ARGUING THAT A CURE ALONE WILL NOT END THE HIV EPIDEMIC, AND THAT ONLY WITH A COORDINATED AND ENDURING COMMITMENT CAN ANY DISEASE BE CONTROLLED. USING TUBERCULOSIS AND MALARIA AS EXAMPLES, HOW CURES CAN FAIL SHOWS THAT GLOBAL EFFORTS TO ERADICATE WIDESPREAD DISEASES CAN FAIL EVEN WHEN EFFECTIVE CURES ARE AVAILABLE. DESPITE TUBERCULOSIS AND MALARIA BEING PREVENTABLE AND CURABLE, TWO MILLION PEOPLE DIE EVERY YEAR FROM THESE DISEASES. IN JUNE 2017, AMFAR PUBLISHED DERAILING PROGRESS: THE HUMAN IMPACT OF THE U.S. FY2018 GLOBAL HEALTH BUDGET, AN INFOGRAPHIC SHOWING THE IMPACT OF $800 MILLION IN PROPOSED CUTS TO THE U.S. PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR) AND USAID IN FISCAL YEAR 2018, A 17% DECREASE. SUCH A SUBSTANTIAL DECREASE COULD CAUSE MORE THAN 1 MILLION HIV TREATMENT DISRUPTIONS FOR BOTH CHILDREN AND ADULTS, NEW HIV INFECTIONS, AND 146,000 PREVENTABLE AIDS-RELATED DEATHS. IN AUGUST 2017, AMFAR PUBLISHED AN ANALYSIS REVEALING THAT NATIONAL STRATEGIC PLANS (NSPS) ON HIV/AIDS FOR COUNTRIES IN SUB-SAHARAN AFRICA DO NOT CONSISTENTLY DISAGGREGATE HIV TARGETS BY SEX, OR CREATE TARGETS DESIGNED TO ADVANCE GENDER EQUALITY. NSPS ARE PLANNING DOCUMENTS THAT SET PRIORITIES AND TARGETS FOR A COUNTRYS RESPONSE TO THE HIV EPIDEMIC. THE REPORT WAS PUBLISHED IN THE JOURNAL HEALTH POLICY AND PLANNING. AMFAR ALSO PUBLISHED AN ISSUE BRIEF OUTLINING THE POTENTIAL IMPACT OF THE MEXICO CITY POLICY (MCP) ON GLOBAL AIDS FUNDING. MCP HAS HISTORICALLY PROHIBITED U.S. FAMILY PLANNING FUNDING FOR NON-U.S. NONGOVERNMENTAL ORGANIZATIONS PERFORMING OR PROMOTING ABORTION. PRESIDENT REAGAN INTRODUCED THE MEASURE IN 1984 AND IT HAS GONE BACK AND FORTH EVER SINCE. AFTER BEING REPEALED BY PRESIDENT OBAMA, THE POLICY HAS BEEN REVIVED AND EXPANDED BY THE TRUMP ADMINISTRATION. IAS 2017 AMFARS PUBLIC POLICY OFFICE PARTICIPATED IN THE 9TH INTERNATIONAL AIDS SOCIETY CONFERENCE ON HIV SCIENCE (IAS 2017) IN PARIS IN JULY. THE OFFICE CO-SPONSORED A TWO-HOUR SATELLITE SESSION, WITH FHI 360/LINKAGES, USAID, AND THE CDC, TITLED "BETTER DATA, BETTER PROGRAMMES: HOW IMPLEMENTATION SCIENCE IS TRANSFORMING THE HIV RESPONSE FOR KEY POPULATION." THE SEMINAR FEATURED TWO AMFAR-FUNDED STUDIES: "GENDER-AFFIRAMATIVE TRANSGENDER CARE TO IMPROVE THE HIV TREATMENT CASCADE" BY DR. JAVIER LAMA OF ASOCIACION CIVIL IMPACTA SALUD Y EDUCACION (IMPACTA) IN LIMA, PERU AND "COMMUNITY-BASED AND ONLINE STRATEGIES FOR TESTING, TREATMENT AND PREP AMONG MSM AND TRANSGENDER PERSONS IN THAILAND" BY DR. NITTAYA PHANUPHAK OF THE THAI RED CROSS AIDS RESEARCH CENTRE IN BANKOK. ALSO AT THE CONFERENCE, AMFAR POLICY ASSOCIATE JENNIFER SHERWOOD PRESENTED A POSTER TITLED "HIV RISK FACTORS AND ASSOCIATED HEALTH OUTCOMES AMONG SEXUAL MINORITY WOMEN IN THE THE UNITED STATES. "HER COLLEAGUE, POLICY ASSOCIATE ALANA SHARP, PRESENTED TWO POSTERS: "QUALITY ASSESSMENT OF NATIONAL STRATEGIC PLAN TARGETS"GLOBAL FUND FUNDING TRANSITION READINESS IN THE MIDDLE-INCOME COUNTRIES". IN THE NEWS IN MARCH 2017, AMFAR SENIOR POLICY AND MEDICAL ADVISOR DR. SUSAN BLUMENTHAL PENNED AN OP-ED FOR NATIONAL WOMEN AND GIRLS HIV/AIDS AWARENESS DAY WARNING OF THE IMPLICATIONS OF REPEALING THE AFFORDABLE CARE ACT AND LIMITING ACCESS TO HEALTHCARE. SHE WROTE THAT SUCH ACTION COULD RESULT IN A POTENTIAL RESURGENCE OF HIV INFECTION IN THE U.S., JEOPARDIZE THE LIVES OF PEOPLE WITH HIV, AND REVERSE THE STRIDES THAT HAVE BEEN MADE TO EFFECTIVELY PREVENT AND TREAT THE DISEASE. THE OP-ED WAS PUBLISHED ON THE ADVOCATE AND HUFFPOST. IN JUNE 2017, GREG MILLETT, AMFARS VICE PRESIDENT AND DIRECTOR OF PUBLIC POLICY, WAS WIDELY QUOTED IN A NEW YORK TIMES MAGAZINE ARTICLE TITLED "AMERICA'S HIDDEN H.I.V. EPIDEMIC: WHY DO AMERICA'S BLACK GAY AND BISEXUAL MEN HAVE A HIGHER H.I.V. RATE THAT ANY COUNTRY IN THE WORLD?" THE PIECE FOCUSED ON JACKSON, MS, WHICH HAS THE NATIONS HIGHEST RATE OF GAY AND BISEXUAL MEN (40%) LIVING WITH HIV. ALSO IN JUNE, AMFAR POLICY ASSOCIATE ALANA SHARP AND DR. RAHUL GUPTA, PUBLIC HEALTH COMMISSIONER AND STATE HEALTH OFFICER FOR WEST VIRGINIA, PUBLISHED AN OPINION PIECE IN THE HILL ON THE IMPACT OF PROPOSED CUTS TO THE CDC AND MEDICAID ON EFFORTS TO COMBAT THE OPIOID EPIDEMIC. WEST VIRGINIA HAS THE HIGHEST DRUG-RELATED DEATH RATE IN THE COUNTRY. IN ADDITION, A 2016 CDC ASSESSMENT FOUND THAT 50% OF THE STATE WAS AT HIGH RISK FOR HIV AND HEPATITIS C OUTBREAKS CAUSED BY THE SHARING OF NEEDLES. |
| POLICIES | FORM 990, PART VI, SECTION B LINE 11 - THE FORM 990 WAS PREPARED BY A NATIONALLY RENOWNED ACCOUNTING FIRM IN CONJUNCTION WITH THE ORGANIZATION'S FINANCIAL DEPARTMENT. A COPY OF THE DRAFT FORM 990 WAS CIRCULATED TO THE FULL BOARD OF TRUSTEES FOR DISCUSSION AND COMMENT. EACH BOARD MEMBER WAS PROVIDED AMPLE OPPORTUNITY TO COMMENT ON THE INFORMATION CONTAINED IN THE 990 PRIOR TO ITS FILING WITH THE INTERNAL REVENUE SERVICE. LINE 12 - EACH OFFICER, DIRECTOR, TRUSTEE AND KEY EMPLOYEE OF AMFAR ("FOUNDATION") IS REQUIRED TO ANNUALLY DISCLOSE ANY CONFLICTS OF INTEREST THAT ARISE BY VIRTUE OF EMPLOYMENT, BOARD SERVICE, OR POSITION WITH THE FOUNDATION. THE FOUNDATION MONITORS COMPLIANCE WITH ITS CONFLICT OF INTEREST POLICY THROUGH AN ANNUAL QUESTIONNAIRE/DISCLOSURE STATEMENT THAT IS DISTRIBUTED TO THESE INDIVIDUALS. POTENTIAL CONFLICTS ARE INVESTIGATED IMMEDIATELY. LINE 15 - AMFAR ("FOUNDATION FOR AIDS RESEARCH") UNDERTAKES A THOROUGH PROCESS TO ENSURE THAT THE COMPENSATION IT PAYS TO ITS TOP MANAGEMENT OFFICIAL AND ALL OF ITS OFFICERS AND KEY EMPLOYEES IS REASONABLE GIVEN THE MARKET IN WHICH THE FOUNDATION OPERATES. AN INDEPENDENT CONSULTING FIRM QUALIFIED IN THE AREA OF NONPROFIT COMPENSATION PREPARES AN ANALYSIS OF MARKET COMPENSATION RANGES BY JOB FUNCTION AND PRESENTS IT TO THE COMPENSATION COMMITTEE OF THE BOARD. ON THE BASIS OF THIS INFORMATION, STAFF COMPENSATION IS DETERMINED ACCORDING TO SALARY RANGES APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD, IN CONSULTATION WITH THE CEO AND CFO. CEO COMPENSATION IS REVIEWED AND DETERMINED BY THE COMPENSATION COMMITTEE OF THE BOARD UTILIZING THE INDEPENDENT CONSULTANT ANALYSIS. |
| DISCLOSURE | FORM 990, PART VI, SECTION C LINE 19 - AMFAR MAKES ITS FORM 990 AVAILABLE TO THE PUBLIC BY RETAINING A COPY AT ITS PLACE OF BUSINESS AND ON ITS WEBSITE, WWW.AMFAR.ORG. THE FORM 990 IS LIKEWISE PUBLISHED ON THE INTERNET AT WWW.GUIDESTAR.ORG. THE FOUNDATION'S FINANCIAL STATEMENTS ARE MADE AVAILABLE IN ITS ANNUAL REPORT AND ON ITS WEBSITE. THE FOUNDATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT ORDINARILY MADE AVAILABLE TO THE PUBLIC, BUT, IF REQUESTED, WILL BE PROVIDED AT MANAGEMENT'S DISCRETION. |
| FUNCTIONAL EXPENSES | PART IX, LINES 1 & 3 THE FOUNDATION FOR AIDS RESEARCH REPORTS ITS GRANTS NET OF GRANT RETURNS OR RECOVERIES. PERIODICALLY, GRANTS REMITTED TO CHARITABLE ORGANIZATIONS ARE RETURNED TO AMFAR FOR A VARIETY OF REASONS. ON SCHEDULES F & I, GRANTS ARE REPORTED IRRESPECTIVE OF WHETHER THEY WERE ULTIMATELY RETURNED TO AMFAR SINCE CATEGORIZING THE "RETURNED" AMOUNTS WOULD BE TIME CONSUMING. THEREFORE, AMOUNTS REPORTED ON PART IX, LINE 1 WILL NOT TIE TO TOTAL GRANTS ON SCHEDULE I; AMOUNTS REPORTED ON PART IX, LINE 3 WILL NOT TIE TO TOTAL GRANTS ON SCHEDULE F. |
Comments